{"content":"<li class=\"n-box-item date-title\" data-end=\"1568347199\" data-start=\"1568260800\" data-txt=\"Monday, December 23, 2019\">Thursday, September 12, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3499069\" data-ts=\"1568325457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499069-slca-pk-lxrx-and-advm-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SLCA, PK, LXRX and ADVM among notable after hours movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color=\"green\">+20.3%</font>. <a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a> <font color=\"green\">+12.7%</font>. <a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a> <font color=\"green\">+5%</font>. <a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/PK' title='Park Hotels & Resorts Inc.'>PK</a> <font color=\"green\">+3.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/SLCA' title='U.S. Silica Holdings, Inc.'>SLCA</a> <font color=\"red\">-6%</font>. <a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color=\"red\">-3.3%</font>. <a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a> <font color=\"red\">-2.8%</font>. <a href='https://seekingalpha.com/symbol/AZUL' title='Azul S.A.'>AZUL</a> <font color=\"red\">-2.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499069\" data-linked=\"SLCA, PK, LXRX and ADVM among notable after hours movers\" data-tweet=\"$VNCE $DRAD $MGNX - SLCA, PK, LXRX and ADVM among notable after hours movers https://seekingalpha.com/news/3499069-slca-pk-lxrx-and-advm-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499069-slca-pk-lxrx-and-advm-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499067\" data-ts=\"1568324085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499067-park-hotels-moves-to-midcap-400-inogen-joins-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Park Hotels moves to MidCap 400; Inogen joins SmallCap 600</a></h4><ul>   <li>Park Hotels &amp; Resorts (NYSE:<a href='https://seekingalpha.com/symbol/PK' title='Park Hotels & Resorts Inc.'>PK</a>) is <a href=\"https://us.spindices.com/documents/indexnews/announcements/20190912-993759/993759_park6chesapeake4inogen.pdf?force_download=true\" target=\"_blank\">moving up</a> to the S&amp;P MidCap 400 index, thanks to an acquisition of Chesapeake Lodging Trust (NYSE:<a href='https://seekingalpha.com/symbol/CHSP' title='Chesapeake Lodging Trust'>CHSP</a>).</li>    <li>It will replace Inogen (NASDAQ:<a href='https://seekingalpha.com/symbol/INGN' title='Inogen, Inc.'>INGN</a>) there.</li>    <li>Inogen, meanwhile, with a market cap more representative of small caps, will move down to the SmallCap 600 to replace Chesapeake Lodging Trust.</li>    <li>The moves are effective prior to the open on Wednesday, Sept. 18.</li><li><strong>Updated 5:44 p.m.:</strong> Park Hotels is <font color=\"green\">up 3.8%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499067\" data-linked=\"Park Hotels moves to MidCap 400; Inogen joins SmallCap 600\" data-tweet=\"$PK $CHSP $INGN - Park Hotels moves to MidCap 400; Inogen joins SmallCap 600 https://seekingalpha.com/news/3499067-park-hotels-moves-to-midcap-400-inogen-joins-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3499067-park-hotels-moves-to-midcap-400-inogen-joins-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499066\" data-ts=\"1568323597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITCI\" target=\"_blank\">ITCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499066-intra-cellular-files-350m-mixed-shelf\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intra-Cellular files $350M mixed shelf</a></h4><ul>   <li>Intra-Cellular Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies, Inc.'>ITCI</a>) has filed a <a href=\"https://seekingalpha.com/filing/4633843\" target=\"_blank\">$350M mixed shelf registration</a>.</li>    <li>It's also entered a <a href=\"https://seekingalpha.com/filing/4633866\" target=\"_blank\">sales agreement</a> with SVB Leerink where it may offer up to $75M in common stock.</li>    <li>The mixed shelf covers the offer of common stock, preferred stock, debt securities, warrants, rights and/or units.</li>    <li>Proceeds are set for further development and commercialization of ITI-007 and PDE1 programs among other candidates, and general purposes.</li>    <li>Shares are <font color=\"green\">up 2.9%</font> after hours.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3499066\" data-linked=\"Intra-Cellular files $350M mixed shelf\" data-tweet=\"$ITCI - Intra-Cellular files $350M mixed shelf https://seekingalpha.com/news/3499066-intra-cellular-files-350m-mixed-shelf?source=tweet\" data-url=\"https://seekingalpha.com/news/3499066-intra-cellular-files-350m-mixed-shelf\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499062\" data-ts=\"1568322528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDLA\" target=\"_blank\">MDLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499062-medalliaplus-2_9-director-buys-11m-worth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medallia +2.9% as director buys $11M worth</a></h4><ul>   <li>Medallia (NYSE:<a href='https://seekingalpha.com/symbol/MDLA' title='Medallia, Inc.'>MDLA</a>) has <font color=\"green\">gained 2.9%</font> postmarket after the disclosure that director and major holder Douglas Leone purchased shares.</li>    <li>The <a href=\"https://seekingalpha.com/filing/4633665\" target=\"_blank\">SEC filing</a> indicates Leone bought 399,265 shares over the past two days.</li>    <li>On Tuesday, Leone bought 48,241 shares at an average price of $27.965. On Wednesday, he added 351,024 shares at $28.143.</li>    <li>Those near-400,000 shares make up all of Leone's direct ownership; he also has a substantial indirect stake through Sequoia Capital.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499062\" data-linked=\"Medallia +2.9% as director buys $11M worth\" data-tweet=\"$MDLA - Medallia +2.9% as director buys $11M worth https://seekingalpha.com/news/3499062-medalliaplus-2_9-director-buys-11m-worth?source=tweet\" data-url=\"https://seekingalpha.com/news/3499062-medalliaplus-2_9-director-buys-11m-worth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499058\" data-ts=\"1568322240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRAN\" target=\"_blank\">FRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499058-francescasplus-2_7-director-discloses-5000-share-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Francesca&#39;s +2.7% as director discloses 5,000-share purchase</a></h4><ul>   <li>Francesca's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corporation'>FRAN</a>) is <font color=\"green\">up 2.7%</font> after hours, rebounding from a <font color=\"red\">14.8% drop</font> today, after a filing detailing an insider purchase.</li>    <li>Boardmember Richard Emmett has disclosed buying 5,000 shares at an average price of $11.43 yesterday.</li>    <li>That marks an outlay of about $57,150.</li>    <li>Emmett's direct beneficial ownership stands at 26,374 shares after the purchase.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499058\" data-linked=\"Francesca&#39;s +2.7% as director discloses 5,000-share purchase\" data-tweet=\"$FRAN - Francesca&#39;s +2.7% as director discloses 5,000-share purchase https://seekingalpha.com/news/3499058-francescasplus-2_7-director-discloses-5000-share-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3499058-francescasplus-2_7-director-discloses-5000-share-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499051\" data-ts=\"1568321289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTTR\" target=\"_blank\">RTTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499051-ritter-pharmas-rp-g28-flunks-late-stage-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ritter Pharma&#39;s RP-G28 flunks late-stage study</a></h4><ul><li>Thinly traded nano cap Ritter Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals, Inc.'>RTTR</a>) is poised for a significant down move after <a href=\"https://seekingalpha.com/pr/17631164-ritter-pharmaceuticals-reports-top-line-results-liberatus-phase-3-trial-rp-g28-lactose\" target=\"_blank\">announcing </a>that a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03597516?spons=ritter+pharmaceuticals&amp;phase=2&amp;rank=1\" target=\"_blank\">Phase 3 clinical trial</a> evaluating lead candidate RP-G28 for the treatment of lactose intolerance &#40;LI&#41; failed to achieve the primary endpoint.</li><li>RP-G28 did not separate from placebo as measured by the change from baseline in LI symptom composite score at day 61, the primary objective. Specifically, the mean reduction in the treatment group was 3.159 compared to a reduction of 3.420 in the control group (p=0.106).</li><li>The first secondary endpoint, the proportion of patients with meaningful reductions in LI symptom composite scores at day 61, was also not met.</li><li>The company plans to complete the data analysis before deciding on next steps.</li><li><a href=\"https://www.ritterpharmaceuticals.com/product-platform/product-pipeline\" target=\"_blank\">RP-G28</a>, a highly purified <a href=\"https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/galactooligosaccharide\" target=\"_blank\">galactooligosaccharide</a>, is designed to stimulate the growth of lactose-metabolizing bacteria in the colon.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499051\" data-linked=\"Ritter Pharma&#39;s RP-G28 flunks late-stage study\" data-tweet=\"$RTTR - Ritter Pharma&#39;s RP-G28 flunks late-stage study https://seekingalpha.com/news/3499051-ritter-pharmas-rp-g28-flunks-late-stage-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3499051-ritter-pharmas-rp-g28-flunks-late-stage-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499036\" data-ts=\"1568319966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499036-broadcomminus-1_7-after-cautious-outlook-in-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom -1.7% after cautious outlook in Q3 report</a></h4><ul>   <li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Inc.'>AVGO</a>) beat profit expectations yet again in <a href=\"https://seekingalpha.com/news/3499031-broadcom-eps-beats-0_03-revenue-line\" target=\"_blank\">fiscal Q3 earnings</a> as revenues came in in line with near double-digit growth.</li>    <li>Shares are <font color=\"red\">off 1.7%</font> after hours.</li>    <li>Analysts had lowered the bar over the past quarter, with a few dozen downward revisions in expectations for EPS and revenues.</li>    <li>Revenues grew 9% and were roughly flat sequentially, at $5.515B. Gross margin was 55%, up from a year-ago 51.7% and down slightly from last quarter's 56%.</li>    <li>Operating income fell to $865M from a year-ago $1.34B and last quarter's $970M.</li>    <li>Revenue by segment: Semiconductor solutions, $4.35B (down 5%); Infrastructure software, $1.14B (up 132%); IP Licensing, $22M (up 633%).</li>    <li>Free cash flow was $2.31B (up 8%); operating cash flow was $2.42B while capex was $112M. The company returned $2B-plus to shareholders via $1.1B in dividends and $1B in share buybacks/eliminations.</li>    <li>It's sticking with full-year guidance for revenue of $22.5B (vs. consensus for $22.6B) with an operating margin (non-GAAP) of 52.5%. \"We remain fully committed to maintaining our investment grade credit rating and, looking forward, we intend to focus on deleveraging our balance sheet.\"</li>    <li><a href=\"https://edge.media-server.com/mmc/p/qbefibnv\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17631169-broadcom-inc-announces-third-quarter-fiscal-year-2019-financial-results-quarterly-dividend\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3499036\" data-linked=\"Broadcom -1.7% after cautious outlook in Q3 report\" data-tweet=\"$AVGO - Broadcom -1.7% after cautious outlook in Q3 report https://seekingalpha.com/news/3499036-broadcomminus-1_7-after-cautious-outlook-in-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3499036-broadcomminus-1_7-after-cautious-outlook-in-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499032\" data-ts=\"1568319581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOSY\" target=\"_blank\">MOSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499032-mosys-regains-nasdaq-compliance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoSys regains Nasdaq compliance</a></h4><ul><li>MoSys (NASDAQ:<a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a>) <a href=\"https://seekingalpha.com/pr/17631141-mosys-regains-compliance-nasdaq-bid-price-listing-requirement\" target=\"_blank\">announces</a> regaining compliance after exceeding the $1 minimum closing bid price for 10 consecutive trading days.</li><li>Related: MOSY <a href=\"https://seekingalpha.com/news/3494973-mosys-plus-8-percent-ahead-1minus-20-reverse-split\" target=\"_blank\">announced</a> a 1-for-20 reverse split late last month to regain Nasdaq compliance.</li><li>MOSY shares are <font color=\"green\">up 2%</font> after hours to $2.58.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499032\" data-linked=\"MoSys regains Nasdaq compliance\" data-tweet=\"$MOSY - MoSys regains Nasdaq compliance https://seekingalpha.com/news/3499032-mosys-regains-nasdaq-compliance?source=tweet\" data-url=\"https://seekingalpha.com/news/3499032-mosys-regains-nasdaq-compliance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499017\" data-ts=\"1568318943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNCE\" target=\"_blank\">VNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499017-vince-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vince beats on revenue</a></h4><ul><li>Vince (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>): Q2 GAAP EPS of $0.08.</li><li>Revenue of $71.35M (+13.0% Y/Y) <font color=\"green\">beats by $2.75M</font>.</li><li>Shares <font color=\"green\">+7.05%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17631132-vince-holding-corp-reports-second-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3499017\" data-linked=\"Vince beats on revenue\" data-tweet=\"$VNCE - Vince beats on revenue https://seekingalpha.com/news/3499017-vince-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3499017-vince-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499007\" data-ts=\"1568318069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTSI\" target=\"_blank\">FTSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499007-fts-international-mrc-global-propetro-all-downgraded-cowen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTS International, MRC Global, ProPetro all downgraded at Cowen</a></h4><ul><li>FTS International (<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a> <font color='red'>-12.6%</font>) plunges after Cowen analyst Marc Bianchi <a href=\"https://thefly.com/thestreet/realmoney/index.php/FTSIid2962212/FTSI-FTS-International-downgraded-to-Market-Perform-from-Outperform-at-Cowen\" target=\"_blank\">downgrades</a> shares to Market  Perform from Outperform with a $5 price target, saying the company no longer offers  sufficient upside as its fracking market economics do not work amid an already oversupplied market.</li><li>Bianchi <a href=\"https://thefly.com/thestreet/realmoney/index.php/MRCid2962199/MRC-MRC-Global-downgraded-to-Market-Perform-from-Outperform-at-Cowen\" target=\"_blank\">also downgrades</a> MRC Global (<a href='https://seekingalpha.com/symbol/MRC' title='MRC Global Inc.'>MRC</a> <font color='red'>-3.2%</font>) to Market Perform with a $14 price target following the company's reduced Q3 revenue outlook and  comments that previous guidance can no longer be  relied upon.</li><li>Cowen <a href=\"https://thefly.com/thestreet/realmoney/index.php/PUMPid2962206/PUMP-ProPetro-Holding-downgraded-to-Market-Perform-from-Outperform-at-Cowen\" target=\"_blank\">also cuts</a> ProPetro (<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro Holding Corp.'>PUMP</a> <font color='green'>+0.7%</font>) to Market  Perform with an $11 target, noting the company has passed its  30-day review period since announcing an internal issue  and no update has been given.</li><li>FTSI's average <a href=\"https://seekingalpha.com/symbol/FTSI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Hold, its <a href=\"https://seekingalpha.com/symbol/FTSI/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> is Neutral, and its <a href=\"https://seekingalpha.com/symbol/FTSI/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Very Bearish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499007\" data-linked=\"FTS International, MRC Global, ProPetro all downgraded at Cowen\" data-tweet=\"$FTSI $MRC $PUMP - FTS International, MRC Global, ProPetro all downgraded at Cowen https://seekingalpha.com/news/3499007-fts-international-mrc-global-propetro-all-downgraded-cowen?source=tweet\" data-url=\"https://seekingalpha.com/news/3499007-fts-international-mrc-global-propetro-all-downgraded-cowen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499005\" data-ts=\"1568317672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WCG\" target=\"_blank\">WCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499005-health-insurers-in-red-ahead-of-dem-debate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers in red ahead of Dem debate</a></h4><ul><li>Health insurers/managed care providers are under modest pressure ahead of tonight's debate between the Democratic frontrunners for President. Joe Biden is advocating a voluntary approach to expanding Medicare coverage to more Americans while Bernie Sanders and Elizabeth Warren want to go \"all in\" with a single-payer system that would decimate private insurers.</li><li>Selected tickers: WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"red\">-2.3%</font>), UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"red\">-1.7%</font>), Triple-S Management (<a href='https://seekingalpha.com/symbol/GTS' title='Triple-S Management Corporation'>GTS</a> <font color=\"red\">-5.8%</font>), Molina Healthcare (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"red\">-3.6%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"red\">-2.7%</font>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-1.5%</font>), Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"red\">-3.8%</font>), Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"red\">-0.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3499005\" data-linked=\"Health insurers in red ahead of Dem debate\" data-tweet=\"$WCG $UNH $GTS - Health insurers in red ahead of Dem debate https://seekingalpha.com/news/3499005-health-insurers-in-red-ahead-of-dem-debate?source=tweet\" data-url=\"https://seekingalpha.com/news/3499005-health-insurers-in-red-ahead-of-dem-debate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499003\" data-ts=\"1568315789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499003-fda-oks-ardelyxs-tenapanor-for-ibs-c\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Ardelyx&#39;s tenapanor for IBS-C</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17631058-ardelyx-receives-fda-approval-ibsrela-tenapanor-nhe3-sodium-transport-inhibitor-treatment\" target=\"_blank\">approves</a> Ardelyx's (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) IBSRELA (tenapanor) for the treatment of adults with irritable bowel syndrome with constipation (IBS-C).</li><li>Management will host a conference call today at 4:30 pm ET to discuss the approval.</li><li><strong>Update</strong>: Shares will resume trading at 3:40 pm ET.</li><li><strong>Update</strong>: Shares down <font color=\"red\">1%</font> on resumption of trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499003\" data-linked=\"FDA OKs Ardelyx&#39;s tenapanor for IBS-C\" data-tweet=\"$ARDX - FDA OKs Ardelyx&#39;s tenapanor for IBS-C https://seekingalpha.com/news/3499003-fda-oks-ardelyxs-tenapanor-for-ibs-c?source=tweet\" data-url=\"https://seekingalpha.com/news/3499003-fda-oks-ardelyxs-tenapanor-for-ibs-c\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498999\" data-ts=\"1568314751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORBC\" target=\"_blank\">ORBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498999-orbcommplus-4-after-insider-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orbcomm +4% after insider purchase</a></h4><ul><li>Orbcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/ORBC' title='ORBCOMM Inc.'>ORBC</a>) CFO and CAO Milcos Constantine <a href=\"https://seekingalpha.com/filing/4633023\" target=\"_blank\">discloses </a>purchasing 15K shares at an average price of $5.25/share.</li><li>The purchase raised his stake to roughly 48K shares.</li><li>ORBC shares are <font color=\"green\">up 4.3%</font> to $5.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498999\" data-linked=\"Orbcomm +4% after insider purchase\" data-tweet=\"$ORBC - Orbcomm +4% after insider purchase https://seekingalpha.com/news/3498999-orbcommplus-4-after-insider-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3498999-orbcommplus-4-after-insider-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498997\" data-ts=\"1568314678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498997-dmrc-dxc-enph-and-evh-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DMRC, DXC, ENPH and EVH among tech movers</a></h4><ul><li><strong>Gainers: </strong>One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"green\">+15%</font>. Cambium Networks Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CMBM' title='Cambium Networks Corporation'>CMBM</a>) <font color=\"green\">+11%</font>. HC2 Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a>) <font color=\"green\">+10%</font>. Digimarc Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DMRC' title='Digimarc Corporation'>DMRC</a>) <font color=\"green\">+9%</font>. Park City Group (NASDAQ:<a href='https://seekingalpha.com/symbol/PCYG' title='Park City Group, Inc.'>PCYG</a>) <font color=\"green\">+7%</font>.</li> <li><strong>Losers: </strong>Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network, Inc.'>IPDN</a>) <font color=\"red\">-14%</font>. Enphase Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy, Inc.'>ENPH</a>) <font color=\"red\">-12%</font>. DXC Technology Company (NYSE:<a href='https://seekingalpha.com/symbol/DXC' title='DXC Technology Company'>DXC</a>) <font color=\"red\">-11%</font>. Sonim Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SONM' title='Sonim Technologies, Inc.'>SONM</a>) <font color=\"red\">-10%</font>. Evolent Health (NYSE:<a href='https://seekingalpha.com/symbol/EVH' title='Evolent Health, Inc.'>EVH</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498997\" data-linked=\"DMRC, DXC, ENPH and EVH among tech movers\" data-tweet=\"$OSS $CMBM $HCHC - DMRC, DXC, ENPH and EVH among tech movers https://seekingalpha.com/news/3498997-dmrc-dxc-enph-and-evh-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3498997-dmrc-dxc-enph-and-evh-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498995\" data-ts=\"1568314455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498995-ardelyx-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardelyx halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Ardelyx (<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a> <font color=\"red\">-0.9%</font>) pending the release of news, a near certainty that it pertains to the FDA's decision on tenapanor for irritable bowel syndrome with constipation (IBS-C). The agency's action date is today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498995\" data-linked=\"Ardelyx halted pending news\" data-tweet=\"$ARDX - Ardelyx halted pending news https://seekingalpha.com/news/3498995-ardelyx-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3498995-ardelyx-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498989\" data-ts=\"1568313062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498989-google-search-prioritizes-original-stories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google Search prioritizes original stories</a></h4><ul><li>Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color='green'>+1.5%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color='green'>+1.5%</font>) Search is adjusting the news results so that original reporting gets a more prominent and longer-lasting spot at the top of relevant searches.</li><li>In a corporate blog post, the company says the change will elevate the original publication behind a story rather than the resulting reblogs, which could quickly push the breaking story out of the top spots.</li><li>In other Alphabet news, the National Labor Relations Board <a href=\"https://www.cnbc.com/2019/09/12/nlrb-orders-google-to-allow-employees-to-discuss-politics-at-work.html\" target=\"_blank\">has ordered</a> the company to tell employees that they have the right to openly discuss political and workplace concerns.</li><li>The action followed a federal regulator agreement on a proposed settlement on employee free speech complaints.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498989\" data-linked=\"Google Search prioritizes original stories\" data-tweet=\"$GOOG $GOOGL - Google Search prioritizes original stories https://seekingalpha.com/news/3498989-google-search-prioritizes-original-stories?source=tweet\" data-url=\"https://seekingalpha.com/news/3498989-google-search-prioritizes-original-stories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498984\" data-ts=\"1568311544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498984-china-natural-resources-and-parker-drilling-among-energy-materials-gainers-fts-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Natural Resources and Parker Drilling among Energy/Materials gainers; FTS International and Seadrill among losers</a></h4><ul><li><b>Gainers: </b>China Natural Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a>) <font color=\"green\">+13%</font>. Parker Drilling (NYSE:<a href='https://seekingalpha.com/symbol/PKD' title='Parker Drilling Company'>PKD</a>) <font color=\"green\">+12%</font>. Livent (NYSE:<a href='https://seekingalpha.com/symbol/LTHM' title='Livent Corporation'>LTHM</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>FTS International (NYSE:<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a>) <font color=\"red\">-12%</font>. Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"red\">-10%</font>. Nabors Industries (NYSE:<a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a>) <font color=\"red\">-9%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"red\">-9%</font>. Extraction Oil &amp; Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498984\" data-linked=\"China Natural Resources and Parker Drilling among Energy/Materials gainers; FTS International and Seadrill among losers\" data-tweet=\"$CHNR $PKD $LTHM - China Natural Resources and Parker Drilling among Energy/Materials gainers; FTS International and Seadrill among losers https://seekingalpha.com/news/3498984-china-natural-resources-and-parker-drilling-among-energy-materials-gainers-fts-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3498984-china-natural-resources-and-parker-drilling-among-energy-materials-gainers-fts-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498978\" data-ts=\"1568310482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUHN\" target=\"_blank\">RUHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498978-rocket-ride-for-ruhnn-holding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rocket ride for Ruhnn Holding</a></h4><ul> <li>Ruhnn Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RUHN' title='Ruhnn Holding Limited'>RUHN</a>) is <font color=\"green\">up 50.74%</font> on heavy volume without any new corporate releases out.</li> <li>Volume on Ruhnn is already 6X normal activity.</li> <li>Chinese retail names in general are higher off positive news on the tariff front, but the outsized gain in Ruhnn stands out.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498978\" data-linked=\"Rocket ride for Ruhnn Holding\" data-tweet=\"$RUHN - Rocket ride for Ruhnn Holding https://seekingalpha.com/news/3498978-rocket-ride-for-ruhnn-holding?source=tweet\" data-url=\"https://seekingalpha.com/news/3498978-rocket-ride-for-ruhnn-holding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498977\" data-ts=\"1568309513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COUP\" target=\"_blank\">COUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498977-canaccord-bullish-on-coupa-pay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord bullish on Coupa Pay</a></h4><ul><li>More details for yesterday's bullish Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Incorporated'>COUP</a>) <a href=\"https://seekingalpha.com/news/3498722-coupa-gains-bull-canaccord\" target=\"_blank\">start </a>at Canaccord Genuity.</li><li>The firm says it \"couldn\u2019t be more enthusiastic about Coupa Pay\" and thinks COUP \"can maintain a medium term 30+% growth trajectory.\"</li><li>Canaccord started Coupa with a Buy rating and $171 price target. Coupa has an Outperform average <a href=\"https://seekingalpha.com/symbol/COUP/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>COUP shares are <font color=\"green\">up 2.7%</font> to $138.12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498977\" data-linked=\"Canaccord bullish on Coupa Pay\" data-tweet=\"$COUP - Canaccord bullish on Coupa Pay https://seekingalpha.com/news/3498977-canaccord-bullish-on-coupa-pay?source=tweet\" data-url=\"https://seekingalpha.com/news/3498977-canaccord-bullish-on-coupa-pay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498976\" data-ts=\"1568309214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498976-bond-yields-continue-big-move-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bond yields continue big move higher</a></h4><ul><li>The 10-year Treasury yield whooshed lower earlier today after the <a href=\"https://seekingalpha.com/news/3498834\" target=\"_blank\">ECB announced a rate cut</a> and new wave of QE. That's reversed in a big way, with the yield now higher by 5.5 basis points on the session to 1.79%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"red\">-0.7%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"green\">+1.4%</font></li><li>That means the 10-year yield has climbed a whopping 35 basis points in the handful of sessions since Labor Day - if there's been a sharper move higher in recent (or distant) memory, we can't think of it.</li><li>Today's move has brought the 30-year yield up to 2.26%, meaning the Fed Funds rate at 2.25% in no longer the largest number across the yield curve.</li><li>Not complaining are the banks - the SPDR S&amp;P Bank ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a>) is <font color=\"green\">up about 8%</font> since returning from Labor Day weekend.</li><li>Related ETFs: <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity Covington Trust - Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a>, <a href='https://seekingalpha.com/symbol/FINU' title='ProShares Trust - ProShares UltraPro Financial Select Sector'>FINU</a>, <a href='https://seekingalpha.com/symbol/FXO' title='First Trust Financials AlphaDEX ETF'>FXO</a>, <a href='https://seekingalpha.com/symbol/RYF' title='Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight Financials ETF'>RYF</a>, <a href='https://seekingalpha.com/symbol/SEF' title='ProShares Short Financials ETF'>SEF</a>, <a href='https://seekingalpha.com/symbol/FINZ' title='ProShares UltraPro Short Financials ETF'>FINZ</a>, <a href='https://seekingalpha.com/symbol/RWW' title='Oppenheimer Financials Sector Revenue ETF'>RWW</a>, <a href='https://seekingalpha.com/symbol/JHMF' title='John Hancock Exchange-Traded Fund Trust - John Hancock Multifactor Financials ETF'>JHMF</a>, <a href='https://seekingalpha.com/symbol/BNKD' title='BMO MicroSectors U.S. Big Banks Index -3X Inverse Leveraged ETN'>BNKD</a>, <a href='https://seekingalpha.com/symbol/BNKO' title='BMO MicroSectors U.S. Big Banks Index 2X Leveraged ETN'>BNKO</a>, <a href='https://seekingalpha.com/symbol/BNKU' title='BMO MicroSectors U.S. Big Banks Index 3X Leveraged ETN'>BNKU</a>, <a href='https://seekingalpha.com/symbol/KNAB' title='BMO MicroSectors U.S. Big Banks Index Inverse ETN'>KNAB</a>, <a href='https://seekingalpha.com/symbol/BNKZ' title='BMO MicroSectors U.S. Big Banks Index -2X Inverse Leveraged ETN'>BNKZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3498976\" data-linked=\"Bond yields continue big move higher\" data-tweet=\"$TLT $TBT $KBE - Bond yields continue big move higher https://seekingalpha.com/news/3498976-bond-yields-continue-big-move-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3498976-bond-yields-continue-big-move-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498965\" data-ts=\"1568307673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDC\" target=\"_blank\">SDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498965-smiledirectclub-flops-in-u-s-debut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SmileDirectClub flops in U.S. debut</a></h4><ul><li>IPO SmileDirectClub (<a href='https://seekingalpha.com/symbol/SDC' title='SmileDirectClub, Inc.'>SDC</a> <font color=\"red\">N/A</font>), a direct competitor of Align Technology (<a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a> <font color=\"red\">-2.3%</font>), stumbles out of the gate in its first day of trading. Shares are down <font color=\"red\">16%</font> from its $23 offer price on turnover of over 24M.</li><li>Adding to the sour mood is a Forbes piece citing governance concerns with its many related transactions with affiliates of Chairman &amp; CEO David Katzman's investment shop, Camelot Venture Group. The company paid Camelot over $3M last year for consulting services, over $8M to a Camelot affiliate for freight costs and $1M to another Camelot affiliate to lease a private plane (<a href=\"https://www.sec.gov/Archives/edgar/data/1775625/000104746919005062/a2239587zs-1a.htm\" target=\"_blank\">pages 157 - 158 in S-1</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3498965\" data-linked=\"SmileDirectClub flops in U.S. debut\" data-tweet=\"$SDC $ALGN - SmileDirectClub flops in U.S. debut https://seekingalpha.com/news/3498965-smiledirectclub-flops-in-u-s-debut?source=tweet\" data-url=\"https://seekingalpha.com/news/3498965-smiledirectclub-flops-in-u-s-debut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498967\" data-ts=\"1568307598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498967-ocean-power-technologies-only-industrial-gainers-nn-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Technologies only industrial gainers; NN among losers</a></h4><ul><li><b>Gainers: </b>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Tecogen (NASDAQ:<a href='https://seekingalpha.com/symbol/TGEN' title='Tecogen Inc.'>TGEN</a>) <font color=\"red\">-10%</font>. Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"red\">-5%</font>. NN (NASDAQ:<a href='https://seekingalpha.com/symbol/NNBR' title='NN, Inc.'>NNBR</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498967\" data-linked=\"Ocean Power Technologies only industrial gainers; NN among losers\" data-tweet=\"$OPTT $TGEN $HEBT - Ocean Power Technologies only industrial gainers; NN among losers https://seekingalpha.com/news/3498967-ocean-power-technologies-only-industrial-gainers-nn-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3498967-ocean-power-technologies-only-industrial-gainers-nn-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498968\" data-ts=\"1568307556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498968-mdjm-and-cohen-company-among-financial-gainers-cbl-associates-properties-and-exp-world-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MDJM and Cohen &amp; Company among Financial gainers; CBL &amp; Associates Properties and eXp World among losers</a></h4><ul><li><b>Gainers: </b>MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"green\">+12%</font>. Cohen &amp; Company (NYSEMKT:<a href='https://seekingalpha.com/symbol/COHN' title='Cohen & Company Inc.'>COHN</a>) <font color=\"green\">+9%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"green\">+8%</font>. Ladenburg Thalmann Financial Services (NYSEMKT:<a href='https://seekingalpha.com/symbol/LTS' title='Ladenburg Thalmann Financial Services Inc.'>LTS</a>) <font color=\"green\">+7%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-18%</font>. eXp World  (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPI' title='eXp World Holdings, Inc.'>EXPI</a>) <font color=\"red\">-6%</font>. Tiptree (NASDAQ:<a href='https://seekingalpha.com/symbol/TIPT' title='Tiptree Inc.'>TIPT</a>) <font color=\"red\">-6%</font>. Grupo Supervielle (NYSE:<a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498968\" data-linked=\"MDJM and Cohen &amp; Company among Financial gainers; CBL &amp; Associates Properties and eXp World among losers\" data-tweet=\"$MDJH $COHN $PUYI - MDJM and Cohen &amp; Company among Financial gainers; CBL &amp; Associates Properties and eXp World among losers https://seekingalpha.com/news/3498968-mdjm-and-cohen-company-among-financial-gainers-cbl-associates-properties-and-exp-world-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3498968-mdjm-and-cohen-company-among-financial-gainers-cbl-associates-properties-and-exp-world-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498962\" data-ts=\"1568306232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498962-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>Sintx Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SINT' title='Sintx Technologies, Inc.'>SINT</a>) <font color=\"green\">+71%</font>. Ruhnn Holding Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/RUHN' title='Ruhnn Holding Limited'>RUHN</a>) <font color=\"green\">+29%</font>. Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"green\">+19%</font>. T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems, Inc.'>TTOO</a>) <font color=\"green\">+15%</font>. OncoCyte Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"green\">+13%</font>. Libbey (NYSEMKT:<a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a>) <font color=\"green\">+13%</font>. Cyclerion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CYCN' title='Cyclerion Therapeutics, Inc.'>CYCN</a>) <font color=\"green\">+12%</font>. Parker Drilling Company (NYSE:<a href='https://seekingalpha.com/symbol/PKD' title='Parker Drilling Company'>PKD</a>) <font color=\"green\">+12%</font>. MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"green\">+11%</font>. vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics Inc.'>VTVT</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers: </strong>Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a>) <font color=\"red\">-76%</font>. Adverum Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a>) <font color=\"red\">-31%</font>. Tailored Brands (NYSE:<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc.'>TLRD</a>) <font color=\"red\">-26%</font>. Salarius Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SLRX' title='Salarius Pharmaceuticals, Inc.'>SLRX</a>) <font color=\"red\">-21%</font>. MasterCraft Boat Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a>) <font color=\"red\">-22%</font>. Celyad SA (NASDAQ:<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad SA'>CYAD</a>) <font color=\"red\">-22%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-18%</font>. Francesca's Holdings Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corporation'>FRAN</a>) <font color=\"red\">-17%</font>. American Renal Associates Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings, Inc.'>ARA</a>) <font color=\"red\">-16%</font>. DXC Technology (NYSE:<a href='https://seekingalpha.com/symbol/DXC' title='DXC Technology Company'>DXC</a>) <font color=\"red\">-16%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498962\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SINT $RUHN $JAGX - Midday Gainers / Losers https://seekingalpha.com/news/3498962-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3498962-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498957\" data-ts=\"1568305330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498957-mastercraft-warning-hits-boating-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MasterCraft warning hits boating sector</a></h4><ul> <li>Weak guidance from MasterCraft (<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a> <font color='red'>-22.4%</font>) is spilling over to impact the broad boating sector.</li><li>The three words from MasterCraft that seem to be resonating with investors are \"eroding dealer sentiment.\"</li> <li>Malibu Boats (<a href='https://seekingalpha.com/symbol/MBUU' title='Malibu Boats, Inc.'>MBUU</a> <font color='red'>-4.5%</font>), MarineMax (<a href='https://seekingalpha.com/symbol/HZO' title='MarineMax, Inc.'>HZO</a> <font color='red'>-3.5%</font>), Brunswick (<a href='https://seekingalpha.com/symbol/BC' title='Brunswick Corporation'>BC</a> <font color='red'>-0.6%</font>) and Marine Products (<a href='https://seekingalpha.com/symbol/MPX' title='Marine Products Corporation'>MPX</a> <font color='red'>-0.4%</font>) are all lower on the day to varying degrees.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3498917-mastercraft-minus-19-percent-guidance-disappoints\" target=\"_blank\">MasterCraft -19% after guidance disappoints</a> (Sept. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498957\" data-linked=\"MasterCraft warning hits boating sector\" data-tweet=\"$MCFT $MBUU $HZO - MasterCraft warning hits boating sector https://seekingalpha.com/news/3498957-mastercraft-warning-hits-boating-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3498957-mastercraft-warning-hits-boating-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498955\" data-ts=\"1568305162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498955-biogen-down-3-on-tecfidera-patent-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen down 3% on Tecfidera patent review</a></h4><ul><li>Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"red\">-2.6%</font>) slips on average volume in apparent response to a decision by the USPTO's Patent Trial and Appeal Board &#40;PTAB&#41; to review its U.S. Patent No. 8,399,514 ('514 patent) covering the daily dosing regimen of 480 mg of MS med Tecfidera (dimethyl fumarate). Osaka, Japan-based Sawai Pharmaceutical Co., Ltd. is challenging the validity of the patent in hopes of marketing a generic version.</li><li>Mylan challenged the same patent earlier this year.</li><li>Generic companies have been after the '514 patent for some time. The PTAB <a href=\"https://investors.biogen.com/news-releases/news-release-details/uspto-dismisses-inter-partes-review-petition-biogens-patent-514\" target=\"_blank\">declined to institute</a> an inter partes review in September 2015.</li><li>Tecfidera is the company's top seller, accounting for ~32% of its Q2 revenues.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498955\" data-linked=\"Biogen down 3% on Tecfidera patent review\" data-tweet=\"$BIIB - Biogen down 3% on Tecfidera patent review https://seekingalpha.com/news/3498955-biogen-down-3-on-tecfidera-patent-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3498955-biogen-down-3-on-tecfidera-patent-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498953\" data-ts=\"1568304516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITVPY\" target=\"_blank\">ITVPY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498953-itv-launches-tender-for-up-to-500m-in-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ITV launches tender for up to \u20ac500M in debt</a></h4><ul>   <li>ITV (<a href=\"http://seekingalpha.com/symbol/ITVPY\" target=\"_blank\">ITVPY</a> <font color=\"red\">-4.8%</font>) has announced a <a href=\"https://otp.investis.com/clients/uk/itv/rns/regulatory-story.aspx?newsid=1328610&amp;cid=2140\" target=\"_blank\">tender offer</a> for up to \u20ac500M in notes.</li>    <li>The company is tendering for its 2.125% notes due 2022 (of which there are \u20ac600M outstanding) and 2% notes due 2023 (\u20ac500M outstanding).</li>    <li>Maximum acceptance across both series is \u20ac500M.</li>    <li>The company says it intends to issue a new series of euro-denominated fixed-rate notes.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3498953\" data-linked=\"ITV launches tender for up to \u20ac500M in debt\" data-tweet=\"$ITVPY $ITVPF - ITV launches tender for up to \u20ac500M in debt https://seekingalpha.com/news/3498953-itv-launches-tender-for-up-to-500m-in-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3498953-itv-launches-tender-for-up-to-500m-in-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498949\" data-ts=\"1568304011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498949-consumer-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Vapotherm (NYSE:<a href='https://seekingalpha.com/symbol/VAPO' title='Vapotherm, Inc.'>VAPO</a>) <font color=\"green\">+12%</font>. DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDsTEA Inc.'>DTEA</a>) <font color=\"green\">+10%</font>. Libbey (NYSEMKT:<a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a>) <font color=\"green\">+9%</font>. LKQ (NASDAQ:<a href='https://seekingalpha.com/symbol/LKQ' title='LKQ Corporation'>LKQ</a>) <font color=\"green\">+9%</font>. Funko (NASDAQ:<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>MasterCraft Boat (NASDAQ:<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a>) <font color=\"red\">-22%</font>. Celsius Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a>) <font color=\"red\">-12%</font>. The Alkaline Water (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"red\">-8%</font>. Oxford Industries (NYSE:<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries, Inc.'>OXM</a>) <font color=\"red\">-6%</font>. XPEL (NASDAQ:<a href='https://seekingalpha.com/symbol/XPEL' title='XPEL, Inc.'>XPEL</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498949\" data-linked=\"Consumer - Top 5 Gainers / Losers\" data-tweet=\"$VAPO $DTEA $LBY - Consumer - Top 5 Gainers / Losers https://seekingalpha.com/news/3498949-consumer-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3498949-consumer-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498950\" data-ts=\"1568303923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498950-titan-pharma-down-4-ahead-of-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharma down 4% ahead of equity offering</a></h4><ul><li>Thinly traded nano cap Titan Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color=\"red\">-3.8%</font>) is down on average volume on the heels of its <a href=\"https://www.sec.gov/Archives/edgar/data/910267/000114420419044334/tv529168-s1.htm\" target=\"_blank\">preliminary prospectus</a> for a $12M public offering of stock and warrants. Specific prices and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498950\" data-linked=\"Titan Pharma down 4% ahead of equity offering\" data-tweet=\"$TTNP - Titan Pharma down 4% ahead of equity offering https://seekingalpha.com/news/3498950-titan-pharma-down-4-ahead-of-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3498950-titan-pharma-down-4-ahead-of-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498947\" data-ts=\"1568303699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VXRT\" target=\"_blank\">VXRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498947-vaxart-down-14-on-planned-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vaxart down 14% on planned equity offering</a></h4><ul><li>Thinly traded nano cap Vaxart (<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a> <font color=\"red\">-13.6%</font>) is down on more than a 5x surge in volume in reaction to its planned <a href=\"https://www.sec.gov/Archives/edgar/data/72444/000104746919005145/a2239642zs-1.htm\" target=\"_blank\">public offering</a> of common stock and warrants. Prices, volumes and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498947\" data-linked=\"Vaxart down 14% on planned equity offering\" data-tweet=\"$VXRT - Vaxart down 14% on planned equity offering https://seekingalpha.com/news/3498947-vaxart-down-14-on-planned-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3498947-vaxart-down-14-on-planned-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498945\" data-ts=\"1568303230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498945-enphase-solaredge-tumble-after-critical-citron-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase, SolarEdge tumble after critical Citron report</a></h4><ul><li>Enphase Energy (<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy, Inc.'>ENPH</a> <font color=\"red\">-9.3%</font>) and Solaredge Technologies (<a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies, Inc.'>SEDG</a> <font color=\"red\">-4.6%</font>) turn sharply lower after a <a href=\"https://citronresearch.com/wp-content/uploads/2019/09/Citron-Reports-on-Enphase-and-Solaredge.pdf\" target=\"_blank\">report from Citron Research</a> says their shares are trading at \"significantly inflated multiples on peak earnings even as a very credible competitive threat is about to enter the solar inverter market.\"</li><li>The report points to Generac (<a href='https://seekingalpha.com/symbol/GNRC' title='Generac Holdings Inc.'>GNRC</a> <font color=\"green\">+0.7%</font>) as a major new competitive entrant with \"the resources and  track record to make a huge dent in both SEDG and ENPH's market shares.\"</li><li>At its investor day, GNRC said it has engaged in productive talks with the largest U.S. residential solar installers in the country, Sunrun (<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun Inc.'>RUN</a> <font color=\"green\">+1.1%</font>) and Vivint Solar (<a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar, Inc.'>VSLR</a> <font color=\"green\">+0.4%</font>), and with the largest U.S. solar distributor, CED Greentech, to distribute its product.</li><li>GNRC is not followed by Wall Street solar analysts, so its commercial launch announced last week has gone completely unnoticed, Citron says.</li><li>Citron thinks SEDG shares are worth $51-$52 and ENPH is worth $6-$7 over the next 6-18 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498945\" data-linked=\"Enphase, SolarEdge tumble after critical Citron report\" data-tweet=\"$ENPH $SEDG $GNRC - Enphase, SolarEdge tumble after critical Citron report https://seekingalpha.com/news/3498945-enphase-solaredge-tumble-after-critical-citron-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3498945-enphase-solaredge-tumble-after-critical-citron-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>162&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498942\" data-ts=\"1568302513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498942-positive-read-on-under-armour\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive read on Under Armour</a></h4><ul> <li>Checks by Pipe Jaffray indicate that promotional activity at Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>, <a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc.'>UA</a>) is down compared to a year ago.</li> <li>PJ analyst Erinn Murphy also observes that UA's HOVR Apex product is sold out of at least one colorway and the HOVR Rise has several sizes that appear to be sold out.</li> <li>The firm keeps an Overweight rating on Under Armour and price target of $30. Piper Jaffray is more confident than the sell-side consensus, SA authors' average rating and <a href=\"https://seekingalpha.com/symbol/UAA/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a>, which are all at Hold/Neutral equivalents.</li><li>UAA is <font color=\"green\">up 0.70%</font> on the day and 21.79% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498942\" data-linked=\"Positive read on Under Armour\" data-tweet=\"$UAA $UA - Positive read on Under Armour https://seekingalpha.com/news/3498942-positive-read-on-under-armour?source=tweet\" data-url=\"https://seekingalpha.com/news/3498942-positive-read-on-under-armour\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498939\" data-ts=\"1568302314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498939-adiplus-1_4-barclays-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADI +1.4% as Barclays turns bullish</a></h4><ul><li>Barclays upgrades Analog Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices, Inc.'>ADI</a>) from Equal-Weight to Overweight and raises the PT from $105 to $130, a 13% upside to yesterday's close.</li><li>Analyst Blayne Curtis sees the company as the \"clearest winner in Massive MIMO.\"</li><li>The analyst sees Massive Multiple Input Multiple Output and mmWave silicon doubling to an almost $6B market in 2022. Other potential winners from the trend: Texas Instruments (<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Incorporated'>TXN</a> <font color='green'>+0.8%</font>), NXP Semi (<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors N.V.'>NXPI</a> <font color='green'>+0.6%</font>), and Marvell (<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group Ltd.'>MRVL</a>).</li><li>ADI shares are <font color=\"green\">up 1.4%</font> to $116.59. ADI has an Outperform average <a href=\"https://seekingalpha.com/symbol/ADI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498939\" data-linked=\"ADI +1.4% as Barclays turns bullish\" data-tweet=\"$ADI $TXN $NXPI - ADI +1.4% as Barclays turns bullish https://seekingalpha.com/news/3498939-adiplus-1_4-barclays-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3498939-adiplus-1_4-barclays-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498941\" data-ts=\"1568302042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498941-opec-punts-on-production-cuts-crude-prices-energy-stocks-sink\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OPEC punts on further production cuts; crude prices, energy stocks sink</a></h4><ul><li>Crude oil prices (<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color='red'>-2.3%</font>) are firmly in the red after an OPEC technical meeting brings <a href=\"https://www.cnbc.com/2019/09/12/oil-markets-us-china-trade-war-in-focus.html\" target=\"_blank\">no decision on further production cuts</a> despite a mounting global supply glut and weakening demand growth for crude, instead focusing on bringing Nigerian and Iraqi output down to agreed quotas.</li><li>\"It is <a href=\"https://www.wsj.com/articles/opec-defers-decision-on-oil-output-reduction-11568298481\" target=\"_blank\">effectively a hidden cut</a>, because if countries like Nigeria and Iraq do comply with the voluntary cuts, we will end up with less barrels in the market,\" says one delegate.</li><li>WTI October crude <font color=\"red\">-2.5%</font> to $54.37/bbl, November Brent <font color=\"red\">-2.2%</font> to $59.48/bbl.</li><li>Today's accompanying slide in energy stocks (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-0.6%</font>) has pressured the sector back below its 50-day moving average.</li><li>Among today's biggest decliners: <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color=\"red\">-10.9%</font>, <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Company'>SWN</a> <font color=\"red\">-7.3%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color=\"red\">-5%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color=\"red\">-4.8%</font>, <a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a> <font color=\"red\">-4.4%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"red\">-3.3%</font>, <a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a> <font color=\"red\">-3%</font>, <a href='https://seekingalpha.com/symbol/HP' title='Helmerich & Payne, Inc.'>HP</a> <font color=\"red\">-2.8%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"red\">-2.7%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color=\"red\">-2.5%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity Covington Trust - Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares Trust II - ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/USL' title='United States 12 Month Oil Fund, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3498941\" data-linked=\"OPEC punts on further production cuts; crude prices, energy stocks sink\" data-tweet=\"$USO $XLE $NBR - OPEC punts on further production cuts; crude prices, energy stocks sink https://seekingalpha.com/news/3498941-opec-punts-on-production-cuts-crude-prices-energy-stocks-sink?source=tweet\" data-url=\"https://seekingalpha.com/news/3498941-opec-punts-on-production-cuts-crude-prices-energy-stocks-sink\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>114&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498931\" data-ts=\"1568301027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498931-kroger-retreats-on-light-earnings-call-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kroger retreats on light earnings call guidance</a></h4><ul> <li>Shares of Kroger (<a href='https://seekingalpha.com/symbol/KR' title='The Kroger Co.'>KR</a> <font color='red'>-3.6%</font>) fell sharply during the grocery store operator's earnings conference call.</li> <li>Kroger management was very clear on the <a href=\"http://ir.kroger.com/events-and-presentations\" target=\"_blank\">call</a> that the three-year outlook for $400M in incremental operating profit projection is off the table. Kroger does expect FIFO operating profit growth in 2020 to come in ahead of 2019 confirmed guidance. Q3 EPS is seen as coming at flat compared to a year ago, while the consensus estimate of analysts is $0.03 above the 2018 mark.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3498854-kroger-eps-beats-0_03-misses-revenue\" target=\"_blank\">Kroger EPS beats by $0.03, misses on revenue</a> (Sept. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498865-kroger-plus-1-percent-solid-quarter\" target=\"_blank\">Kroger +1% after solid quarter</a> (Sept. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498931\" data-linked=\"Kroger retreats on light earnings call guidance\" data-tweet=\"$KR - Kroger retreats on light earnings call guidance https://seekingalpha.com/news/3498931-kroger-retreats-on-light-earnings-call-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3498931-kroger-retreats-on-light-earnings-call-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498929\" data-ts=\"1568300624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498929-rh-halted-after-disclosing-potential-convertible-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH halted after disclosing potential convertible note offering</a></h4><ul> <li>RH (<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='green'>+3.2%</font>) says it's considering a $300M convertible note offering due in 2024 in a private offering to qualified institutional buyers.</li><li>If the deal goes through, RH would expect to enter into convertible note hedge and warrant transactions that are designed to offset the effect of dilution from the conversion of the notes up to 100% or more of the common stock price at the time of pricing of the notes.</li>  <li>The retailer says deal proceeds would go to retire debt.</li><li>Shares of RH are under a trading halt, with no resumption time listed at the moment by the Nasdaq.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17630673-rh-exploring-potential-300-million-convertible-notes-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3498929\" data-linked=\"RH halted after disclosing potential convertible note offering\" data-tweet=\"$RH - RH halted after disclosing potential convertible note offering https://seekingalpha.com/news/3498929-rh-halted-after-disclosing-potential-convertible-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3498929-rh-halted-after-disclosing-potential-convertible-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498925\" data-ts=\"1568300584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498925-sintx-technologies-leads-healthcare-gainers-tocagen-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sintx Technologies leads healthcare gainers; Tocagen leads the losers</a></h4><ul><li><b>Gainers: </b>Sintx Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SINT' title='Sintx Technologies, Inc.'>SINT</a>) <font color=\"green\">+62%</font>. Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"green\">+25%</font>. OncoCyte (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"green\">+14%</font>. Moderna (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNA' title='Moderna, Inc.'>MRNA</a>) <font color=\"green\">+13%</font>. vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics Inc.'>VTVT</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a>) <font color=\"red\">-79%</font>. Adverum Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a>) <font color=\"red\">-28%</font>. Celyad (NASDAQ:<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad SA'>CYAD</a>) <font color=\"red\">-23%</font>. American Renal Associates (NYSE:<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings, Inc.'>ARA</a>) <font color=\"red\">-17%</font>. Apellis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a>) <font color=\"red\">-15%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498925\" data-linked=\"Sintx Technologies leads healthcare gainers; Tocagen leads the losers\" data-tweet=\"$SINT $JAGX $OCX - Sintx Technologies leads healthcare gainers; Tocagen leads the losers https://seekingalpha.com/news/3498925-sintx-technologies-leads-healthcare-gainers-tocagen-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3498925-sintx-technologies-leads-healthcare-gainers-tocagen-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498924\" data-ts=\"1568300111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REVG\" target=\"_blank\">REVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498924-rev-group-receives-23-transit-bus-order-part-of-five-year-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REV Group receives 23 transit bus order as part of five-year contract</a></h4><ul><li>REV Group (<a href='https://seekingalpha.com/symbol/REVG' title='REV Group, Inc.'>REVG</a> <font color=\"green\">+3.1%</font>) subsidiary ElDorado National-California has been <a href=\"https://seekingalpha.com/pr/17629739-pace-awards-enc-23-transit-bus-order-part-five-year-contract\" target=\"_blank\">awarded</a> a contract to supply 23 Diesel Axess 30\u2019 buses to Pace, the suburban bus division of the Regional Transportation Authority in the Chicago metropolitan area.</li><li>The contract award is estimated at over $80M in revenue over the contract life, along with related optional vehicle features, spare parts and training.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498924\" data-linked=\"REV Group receives 23 transit bus order as part of five-year contract\" data-tweet=\"$REVG - REV Group receives 23 transit bus order as part of five-year contract https://seekingalpha.com/news/3498924-rev-group-receives-23-transit-bus-order-part-of-five-year-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3498924-rev-group-receives-23-transit-bus-order-part-of-five-year-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498923\" data-ts=\"1568299859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIM\" target=\"_blank\">ALIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498923-alimera-expands-iluvien-distribution-deal-horus-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alimera expands Iluvien distribution deal with Horus; shares ahead 10%</a></h4><ul><li>Based on the successful launch of ILUVIEN (fluocinolone acetonide intravitreal implant) 0.19 mg in France for diabetic macular edema &#40;DME&#41; by <a href=\"https://seekingalpha.com/news/3292511-alimera-establishes-iluvien-distribution-france\" target=\"_blank\">distribution partner</a> Horus Pharma, Alimera Sciences (<a href='https://seekingalpha.com/symbol/ALIM' title='Alimera Sciences, Inc.'>ALIM</a> <font color=\"green\">+9.5%</font>) has <a href=\"https://seekingalpha.com/pr/17629954-alimera-announces-expansion-agreement-distribution-partner-horus-pharma-include-marketing\" target=\"_blank\">agreed to expand</a> its territory to include Benelux (Belgium, the Netherlands, Luxembourg) for both DME and non-infectious posterior uveitis.</li><li>Horus will be responsible for establishing reimbursement in each country for both indications.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498923\" data-linked=\"Alimera expands Iluvien distribution deal with Horus; shares ahead 10%\" data-tweet=\"$ALIM - Alimera expands Iluvien distribution deal with Horus; shares ahead 10% https://seekingalpha.com/news/3498923-alimera-expands-iluvien-distribution-deal-horus-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3498923-alimera-expands-iluvien-distribution-deal-horus-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498921\" data-ts=\"1568299400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLED\" target=\"_blank\">OLED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498921-susquehanna-becomes-lone-oled-bear-sharesminus-4_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna becomes lone OLED bear; shares -4.7%</a></h4><ul><li>Susquehanna cuts Universal Display (NASDAQ:<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a>) from Neutral to Negative and the target from $210 to $130, a 33% downside.</li><li>Analyst Mehdi Hosseini says the current valuation reflects \"best case\" earnings growth, which is likely delayed due to the slow penetration of the smartphone market.</li><li>The analyst thinks increasing material costs, particularly for 5G phones, has prompted Apple to change its 2020 display plans from OLED for all of the new models to keeping a mix of LCD and OLED.</li><li>OLED shares are <font color=\"red\">down 4.7%</font> to $184.10. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/OLED/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a> with Susquehanna becoming its only bear.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498921\" data-linked=\"Susquehanna becomes lone OLED bear; shares -4.7%\" data-tweet=\"$OLED - Susquehanna becomes lone OLED bear; shares -4.7% https://seekingalpha.com/news/3498921-susquehanna-becomes-lone-oled-bear-sharesminus-4_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3498921-susquehanna-becomes-lone-oled-bear-sharesminus-4_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498917\" data-ts=\"1568299179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCFT\" target=\"_blank\">MCFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498917-mastercraftminus-19-after-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MasterCraft -19% after guidance disappoints</a></h4><ul> <li>MasterCraft (NASDAQ:<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a>) sinks after the company's profit beat is overwhelmed by soft guidance.</li> <li>The company guides for sales growth to be down at a low single-digit rate vs. +9% expected and EPS to fall at a high single-digit rate vs. +7% consensus.</li> <li>\"Adverse weather conditions across the country during the all-important selling season, along with eroding dealer sentiment - driven by macro-economic and political uncertainty - resulted in a significant decline in retail activity. As such, our FY20 outlook contemplates lower wholesale shipments at MasterCraft compared to prior-year, particularly in H1 of our fiscal year,\" warns MasterCraft management.</li><li>Shares of MasterCraft are <font color=\"red\">down 18.68%</font> to $14.84 to erase a four-week rally.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498832-mastercraft-boat-eps-beats-0_04-misses-revenue\" target=\"_blank\">MasterCraft Boat EPS beats by $0.04, misses on revenue</a> (Sept. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498917\" data-linked=\"MasterCraft -19% after guidance disappoints\" data-tweet=\"$MCFT - MasterCraft -19% after guidance disappoints https://seekingalpha.com/news/3498917-mastercraftminus-19-after-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3498917-mastercraftminus-19-after-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498916\" data-ts=\"1568298841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498916-amazon-bull-sees-international-prime-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon bull sees international Prime potential</a></h4><ul><li>Jefferies analyst Brent Thill says Amazon's (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+1.6%</font>) growth could accelerate with an overseas Prime membership push.</li><li>Thill notes that overseas penetration remains low and thinks the expansion into Brazil as a sign Amazon is focused on this strategy.</li><li>Thill: \"Increased Prime adoption will remain key to AMZN driving growth across the non-AWS businesses.\"</li><li>Jefferies maintains a Buy rating and $2,300 price target. Amazon has a Buy average <a href=\"https://seekingalpha.com/symbol/AMZN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498916\" data-linked=\"Amazon bull sees international Prime potential\" data-tweet=\"$AMZN - Amazon bull sees international Prime potential https://seekingalpha.com/news/3498916-amazon-bull-sees-international-prime-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3498916-amazon-bull-sees-international-prime-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498914\" data-ts=\"1568298692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGTX\" target=\"_blank\">TGTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498914-tgs-ublituximab-shows-favorable-long-term-safety-profile-in-extension-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TG&#39;s ublituximab shows favorable long-term safety profile in extension study</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17629860-tg-therapeutics-presents-data-ublituximab-35th-annual-congress-european-committee-treatment\" target=\"_blank\">Updated data</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03381170?spons=tg+therapeutics&amp;phase=1&amp;rank=4\" target=\"_blank\">Phase 2 extension study</a> evaluating the long-term safety of TG Therapeutics' (<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color=\"red\">-2.8%</font>) ublituximab, in development for relapsing forms of multiple sclerosis, showed that it continued to be well-tolerated after a median follow-up period of 124.7 weeks with no discontinuations due to adverse events. Infusion-related reactions occurred in 11% of participants (n=5), all mild or moderate.</li><li><a href=\"https://seekingalpha.com/news/3396759-tg-therapeutics-ublituximab-showed-treatment-benefit-mid-stage-ms-study\" target=\"_blank\">Results </a>from the regular Phase 2 trial showed that 93% of treated patients were relapse-free at week 48.</li><li>Two Phase 3 studies, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03277261?spons=tg+therapeutics&amp;phase=2&amp;rank=1\" target=\"_blank\">ULTIMATE 1</a> and <a href=\"https://clinicaltrials.gov/ct2/show/NCT03277248?spons=tg+therapeutics&amp;phase=2&amp;rank=2\" target=\"_blank\">ULTIMATE 2</a>, are in process. Topline data should be available in H2 2020.</li><li>Ublituximab is an anti-CD20 monoclonal antibody.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498914\" data-linked=\"TG&#39;s ublituximab shows favorable long-term safety profile in extension study\" data-tweet=\"$TGTX - TG&#39;s ublituximab shows favorable long-term safety profile in extension study https://seekingalpha.com/news/3498914-tgs-ublituximab-shows-favorable-long-term-safety-profile-in-extension-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3498914-tgs-ublituximab-shows-favorable-long-term-safety-profile-in-extension-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498912\" data-ts=\"1568298639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPY\" target=\"_blank\">SPY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498912-positive-trade-chatter-gives-boost-to-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive trade chatter gives boost to stocks</a></h4><ul><li><a href=\"https://www.bloomberg.com/news/articles/2019-09-12/trump-advisers-consider-interim-china-trade-deal-to-delay-tariffs?srnd=premium\" target=\"_blank\">Bloomberg is reporting</a> Trump administration discussions about a interim trade deal with China that would delay or roll back some U.S. tariffs in exchange for Beijing helping out with intellectual property and some ag buys.</li><li>It's more or less about the 100th repeat of what's now becoming a near-daily event, but that's enough to have some hitting the buy button. The S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) has moved from flat to <font color=\"green\">up 0.5%</font>, and the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>) to <font color=\"green\">up 0.8%</font>.</li><li><strong>Update at 10:55 ET:</strong> Like night follows day, a senior administration official \"absolutely\" denies the above story.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498912\" data-linked=\"Positive trade chatter gives boost to stocks\" data-tweet=\"$SPY $QQQ - Positive trade chatter gives boost to stocks https://seekingalpha.com/news/3498912-positive-trade-chatter-gives-boost-to-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3498912-positive-trade-chatter-gives-boost-to-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498910\" data-ts=\"1568298379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMR\" target=\"_blank\">AMR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498910-alta-mesa-resources-files-for-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alta Mesa Resources files for bankruptcy</a></h4><ul><li>Alta Mesa Resources (<a href='https://seekingalpha.com/symbol/AMR' title='Alta Mesa Resources, Inc.'>AMR</a> <font color='red'>-8.9%</font>) <a href=\"https://www.chron.com/business/energy/article/Alta-Mesa-files-for-bankruptcy-under-former-14433881.ph\" target=\"_blank\">files for Chapter 11 bankruptcy</a> amid  collapsing finances and an SEC investigation into possible fraud, without providing further details.</li><li>The company cites \"a historically challenging commodity price environment and a capital market that is highly constrained for energy companies.\"</li><li>AMR also says interim CEO Jim Hackett has resumed his former role as Executive Chairman, and Mark Castiglione is named CEO after serving as interim Executive VP for Strategy and Corporate Development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498910\" data-linked=\"Alta Mesa Resources files for bankruptcy\" data-tweet=\"$AMR - Alta Mesa Resources files for bankruptcy https://seekingalpha.com/news/3498910-alta-mesa-resources-files-for-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3498910-alta-mesa-resources-files-for-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498907\" data-ts=\"1568297619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLDD\" target=\"_blank\">GLDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498907-great-lakes-bags-dredging-awards-totaling-141m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Lakes bags dredging awards totaling $141M</a></h4><ul><li>Great Lakes Dredge &amp; Dock Corporation (<a href='https://seekingalpha.com/symbol/GLDD' title='Great Lakes Dredge & Dock Corporation'>GLDD</a> <font color='green'>+2.1%</font>) announced the <a href=\"https://seekingalpha.com/pr/17629349-great-lakes-announces-receipt-141-million-awarded-work\" target=\"_blank\">receipt of several major dredging awards</a> totaling $141M.</li><li>The awarded work includes- Jacksonville Deepening Contract B Option (Capital Deepening, Florida, $96.6M); Baltimore Harbor (Maintenance, Maryland, $38.4M) and Boston Harbor (Maintenance, Massachusetts, $5.6M).</li><li>The work is expected to begin in Sept. with completion in late 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498907\" data-linked=\"Great Lakes bags dredging awards totaling $141M\" data-tweet=\"$GLDD - Great Lakes bags dredging awards totaling $141M https://seekingalpha.com/news/3498907-great-lakes-bags-dredging-awards-totaling-141m?source=tweet\" data-url=\"https://seekingalpha.com/news/3498907-great-lakes-bags-dredging-awards-totaling-141m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498906\" data-ts=\"1568297603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLHC\" target=\"_blank\">DLHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498906-dlh-announces-1m-share-repurchase-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DLH announces $1M share repurchase plan</a></h4><ul><li>DLH Holdings (<a href='https://seekingalpha.com/symbol/DLHC' title='DLH Holdings Corp.'>DLHC</a> <font color=\"red\">-5%</font>) Board of directors <a href=\"https://seekingalpha.com/pr/17629997-dlh-announces-1-million-share-repurchase-plan\" target=\"_blank\">approved</a> a new plan to repurchase up to $1M.</li><li>DLH had 12,036,161 shares of common stock outstanding as of September 1, 2019. Company did not set an expiration date for this plan.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498906\" data-linked=\"DLH announces $1M share repurchase plan\" data-tweet=\"$DLHC - DLH announces $1M share repurchase plan https://seekingalpha.com/news/3498906-dlh-announces-1m-share-repurchase-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3498906-dlh-announces-1m-share-repurchase-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498903\" data-ts=\"1568297250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNVC\" target=\"_blank\">NNVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498903-nanoviricides-to-reverse-split-shares-1-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NanoViricides to reverse split shares 1:20</a></h4><ul><li>Aimed at regaining compliance with NYSE American's minimum share price listing requirement, NanoViricides (<a href='https://seekingalpha.com/symbol/NNVC' title='NanoViricides, Inc.'>NNVC</a> <font color=\"red\">-5.5%</font>) will execute a <a href=\"https://seekingalpha.com/pr/17630363-nanoviricides-inc-announces-one-twenty-reverse-stock-split\" target=\"_blank\">1:20 reverse split</a> of its common stock after the close on Monday, September 23. Post-split trading will commence at the open on Tuesday, September 24.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498903\" data-linked=\"NanoViricides to reverse split shares 1:20\" data-tweet=\"$NNVC - NanoViricides to reverse split shares 1:20 https://seekingalpha.com/news/3498903-nanoviricides-to-reverse-split-shares-1-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3498903-nanoviricides-to-reverse-split-shares-1-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498904\" data-ts=\"1568297243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498904-anheuser-buschplus-3-higher-asia-ipo-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anheuser-Busch +3% higher as Asia IPO hopes</a></h4><ul> <li>Anheuser-Busch InBev (NYSE:<a href='https://seekingalpha.com/symbol/BUD' title='Anheuser-Busch InBev SA/NV'>BUD</a>) is <font color=\"green\">up 2.52%</font> after announcing that it plans to raise around <a href=\"https://seekingalpha.com/news/3498760-ab-inbev-revives-plan-hong-kong-listing\" target=\"_blank\">$5B</a> in a Hong Kong IPO for its Budweiser Brewing Co. APAC LTD. unit.</li> <li>The proposed Budweiser Brewing (<a href='https://seekingalpha.com/symbol/BUDBC' title='Budweiser Brewing Company'>BUDBC</a>) offering is smaller than the $9.8B deal that was scrapped in July.</li> <li>\"The market conditions in recent days have improved and provided a good window, in which we should seize the opportunity to go ahead,\" an A-B source tells CNBC. The calmer rhetoric around the U.S.-China trade war and the settling down of protests in Hong Kong could be factors in that sentiment.</li> <li>The Budweiser offering could be done by the end of the month.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3498904\" data-linked=\"Anheuser-Busch +3% higher as Asia IPO hopes\" data-tweet=\"$BUD $BUDBC - Anheuser-Busch +3% higher as Asia IPO hopes https://seekingalpha.com/news/3498904-anheuser-buschplus-3-higher-asia-ipo-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3498904-anheuser-buschplus-3-higher-asia-ipo-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498900\" data-ts=\"1568296829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELH\" target=\"_blank\">CELH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498900-celsius-holdings-announces-pricing-of-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celsius Holdings announces pricing of public offering</a></h4><ul><li>Celsius (<a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='red'>-12%</font>) <a href=\"https://seekingalpha.com/pr/17630518-celsius-holdings-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> public offering of ~6.944M shares of its common stock at a price to the public of $3.6/share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498750-celsius-minus-16-percent-offering-shares-fund-func-food-buy\" target=\"_blank\">Celsius -16%; offering shares to fund Func Food buy</a> (Sept. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3498900\" data-linked=\"Celsius Holdings announces pricing of public offering\" data-tweet=\"$CELH - Celsius Holdings announces pricing of public offering https://seekingalpha.com/news/3498900-celsius-holdings-announces-pricing-of-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3498900-celsius-holdings-announces-pricing-of-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498896\" data-ts=\"1568296247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYTU\" target=\"_blank\">AYTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498896-aytu-bio-to-acquire-innovus-pharma-for-up-to-24m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aytu Bio to acquire Innovus Pharma for up to $24M</a></h4><ul><li>Aytu BioScience (<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a> <font color=\"green\">+1.1%</font>) has agreed to <a href=\"https://seekingalpha.com/pr/17630041-aytu-bioscience-announces-definitive-agreement-acquire-innovus-pharmaceuticals\" target=\"_blank\">acquire</a> Innovus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INNV' title='Innovus Pharmaceuticals, Inc.'>OTCQB:INNV</a> <font color=\"green\">+27.5%</font>) for cash and stock valued up to $24M. Specifically, the deal involves ~4.2M AYTU common shares valued at up to $8M and up to $16M in milestones in the form of contingent value rights (CVRs) to be paid in cash or stock over the next five years if certain revenue and profitability targets are met.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498896\" data-linked=\"Aytu Bio to acquire Innovus Pharma for up to $24M\" data-tweet=\"$AYTU $INNV - Aytu Bio to acquire Innovus Pharma for up to $24M https://seekingalpha.com/news/3498896-aytu-bio-to-acquire-innovus-pharma-for-up-to-24m?source=tweet\" data-url=\"https://seekingalpha.com/news/3498896-aytu-bio-to-acquire-innovus-pharma-for-up-to-24m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498893\" data-ts=\"1568295626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYAD\" target=\"_blank\">CYAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498893-celyad-down-24-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celyad down 24% on equity offering</a></h4><ul><li>Ultra-thinly traded Celyad (<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad SA'>CYAD</a> <font color=\"red\">-23.9%</font>) is down in early trade, albeit on turnover of only 3K shares, on the heels of its global <a href=\"https://seekingalpha.com/pr/17630483-celyad-announces-pricing-20_0-million-global-offering\" target=\"_blank\">offering</a> of 2M ordinary shares via ~1.7M ADSs at $10/ADS and a concurrent private placement of ~283K ordinary shares in Europe and certain other ex-U.S. countries at \u20ac9.08.</li><li>Gross proceeds should be ~$20M (~\u20ac18.2M).</li><li>Underwriters over-allotment is an additional 300K ordinary shares (could be ADSs). Closing date is September 16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498893\" data-linked=\"Celyad down 24% on equity offering\" data-tweet=\"$CYAD - Celyad down 24% on equity offering https://seekingalpha.com/news/3498893-celyad-down-24-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3498893-celyad-down-24-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498888\" data-ts=\"1568295142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APLS\" target=\"_blank\">APLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498888-apellis-pharma-prices-convertible-debt-offering-shares-down-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apellis Pharma prices convertible debt offering; shares down 13%</a></h4><ul><li>Apellis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a> <font color=\"red\">-12.5%</font>) <a href=\"https://seekingalpha.com/pr/17630080-apellis-pharmaceuticals-announces-pricing-offering-convertible-senior-notes\" target=\"_blank\">prices</a> its offering of $220M of 3.500% convertible senior notes due 2026 at par. Initial purchasers will have the option buy an additional $33M of the notes.</li><li>The initial conversion rate is 25.3405 shares per $1,000 principal amount of the notes (~$39.46/share).</li><li>Net proceeds should be ~$212.9M, the majority of which will fund the continued development of APL-2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498888\" data-linked=\"Apellis Pharma prices convertible debt offering; shares down 13%\" data-tweet=\"$APLS - Apellis Pharma prices convertible debt offering; shares down 13% https://seekingalpha.com/news/3498888-apellis-pharma-prices-convertible-debt-offering-shares-down-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3498888-apellis-pharma-prices-convertible-debt-offering-shares-down-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498885\" data-ts=\"1568294859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498885-veonminus-2-sberbank-cuts-to-hold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veon -2% as Sberbank cuts to Hold</a></h4><ul>   <li>Veon (NASDAQ:<a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd.'>VEON</a>) is <font color=\"red\">off 2%</font> premarket following a downgrade to Hold by Sberbank CIB.</li>    <li>The bank cut its price target to $3.05 from $3.32 -- still implying 19.6% upside.</li>    <li>Sell-side analysts rate it <a href=\"https://seekingalpha.com/symbol/VEON/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a>, while <a href=\"https://seekingalpha.com/symbol/VEON/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Neutral</a> and the stock has a <a href=\"https://seekingalpha.com/symbol/VEON/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498885\" data-linked=\"Veon -2% as Sberbank cuts to Hold\" data-tweet=\"$VEON - Veon -2% as Sberbank cuts to Hold https://seekingalpha.com/news/3498885-veonminus-2-sberbank-cuts-to-hold?source=tweet\" data-url=\"https://seekingalpha.com/news/3498885-veonminus-2-sberbank-cuts-to-hold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498881\" data-ts=\"1568294752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGI\" target=\"_blank\">AGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498881-alamos-gold-expands-high-grade-mineralization-island-gold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alamos Gold expands high-grade mineralization at Island Gold</a></h4><ul><li>Alamos Gold (NYSE:<a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc.'>AGI</a>) <font color=\"green\">+4.3%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17629518-alamos-gold-continues-expand-high-grade-mineralization-eastern-main-extensions-island-gold\" target=\"_blank\">reporting new results</a> from surface and underground exploration drilling at the Island Gold Mine, further extending high-grade gold mineralization.</li><li>AGI says its ongoing exploration program at Island Gold has been successful in extending high grade gold mineralization across each of the Main, Western and Eastern Extensions, which has translated into significant growth in mineral reserves and resources since the November 2017 acquisition of Island Gold.</li><li>The 2019 exploration program at Island Gold includes 48K meters of surface directional exploration drilling, 30K meters of underground exploration drilling, and 917 meters of exploration drift development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498881\" data-linked=\"Alamos Gold expands high-grade mineralization at Island Gold\" data-tweet=\"$AGI - Alamos Gold expands high-grade mineralization at Island Gold https://seekingalpha.com/news/3498881-alamos-gold-expands-high-grade-mineralization-island-gold?source=tweet\" data-url=\"https://seekingalpha.com/news/3498881-alamos-gold-expands-high-grade-mineralization-island-gold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498877\" data-ts=\"1568294534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXC\" target=\"_blank\">DXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498877-evercore-slashes-dxc-target-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore slashes DXC target, hits sidelines</a></h4><ul><li>Evercore downgrades DXC (NYSE:<a href='https://seekingalpha.com/symbol/DXC' title='DXC Technology Company'>DXC</a>) from Outperform to In-Line and cuts the target from $63 to $34.</li><li>Yesterday, DXC <a href=\"https://seekingalpha.com/news/3498731-dxc-minus-2_4-percent-appointing-new-ceo\" target=\"_blank\">appointed</a> Accenture vet Mike Salvino as the new CEO.</li><li>DXC shares are <font color=\"red\">down 6.9%</font> pre-market to $33.99. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/DXC\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498877\" data-linked=\"Evercore slashes DXC target, hits sidelines\" data-tweet=\"$DXC - Evercore slashes DXC target, hits sidelines https://seekingalpha.com/news/3498877-evercore-slashes-dxc-target-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3498877-evercore-slashes-dxc-target-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498875\" data-ts=\"1568294370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498875-acb-dlth-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACB, DLTH among premarket losers</a></h4><ul><li>Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a>) <font color=\"red\">-82%</font> after two-part immunotherapy <a href=\"https://seekingalpha.com/news/3498791-tocagen-two-part-immunotherapy-flunks-brain-cancer-study-shares-67-percent-premarket\" target=\"_blank\">flunks</a> brain cancer study.</li><li>Adverum Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a>) <font color=\"red\">-34%</font> on 24-week data from early-stage <a href=\"https://seekingalpha.com/news/3498781-adverum-bio-3-percent-premarket-data-early-stage-advmminus-022-ivt-gene-therapy-trial\" target=\"_blank\">ADVM-022</a> IVT gene therapy trial.</li><li>Celyad SA (NASDAQ:<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad SA'>CYAD</a>) <font color=\"red\">-29%</font>.</li><li>Tailored Brands (NYSE:<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc.'>TLRD</a>) <font color=\"red\">-27%</font> on <a href=\"https://seekingalpha.com/news/3498664-tailored-brands-eps-beats-0_03-revenue-line\" target=\"_blank\">Q2 earnings</a>.</li><li>Duluth Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/DLTH' title='Duluth Holdings Inc.'>DLTH</a>) <font color=\"red\">-15%</font> on <a href=\"https://seekingalpha.com/news/3498856-duluth-holdings-eps-misses-0_07-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li>Celsius Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a>) <font color=\"red\">-14%</font> after <a href=\"https://seekingalpha.com/news/3498750-celsius-minus-16-percent-offering-shares-fund-func-food-buy\" target=\"_blank\">filing</a> a prospectus to offer shares via B. Riley.</li><li>MasterCraft Boat Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a>) <font color=\"red\">-15%</font> on <a href=\"https://seekingalpha.com/news/3498832-mastercraft-boat-eps-beats-0_04-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"red\">-12%</font>.</li><li>Avaya Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AVYA' title='Avaya Holdings Corp.'>AVYA</a>) <font color=\"red\">-12%</font> on <a href=\"https://seekingalpha.com/news/3498842-avaya-considering-ringcentral-jv-shares-minus-9-percent\" target=\"_blank\">RingCentral</a> JV update.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3498730-aurora-cannabis-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3498714-catalyst-11-percent-hours-stock-offering\" target=\"_blank\">announcing</a> stock offering.</li><li>Top Ships (NASDAQ:<a href='https://seekingalpha.com/symbol/TOPS' title='Top Ships Inc.'>TOPS</a>) <font color=\"red\">-9%</font>.</li><li>DXC Technology (NYSE:<a href='https://seekingalpha.com/symbol/DXC' title='DXC Technology Company'>DXC</a>) <font color=\"red\">-7%</font> after appointing <a href=\"https://seekingalpha.com/news/3498731-dxc-minus-2_4-percent-appointing-new-ceo\" target=\"_blank\">new CEO</a>.</li><li>Francesca's Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corporation'>FRAN</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498875\" data-linked=\"ACB, DLTH among premarket losers\" data-tweet=\"$TOCA $ADVM $CYAD - ACB, DLTH among premarket losers https://seekingalpha.com/news/3498875-acb-dlth-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3498875-acb-dlth-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498871\" data-ts=\"1568293698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498871-au-hmy-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AU, HMY among premarket gainers</a></h4><ul><li>Sintx Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SINT' title='Sintx Technologies, Inc.'>SINT</a>) <font color=\"green\">+53%</font>.</li><li>Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) <font color=\"green\">+18%</font> on positive h-Patch CBD <a href=\"https://seekingalpha.com/news/3498818-valeritas-holdings-41-percent-premarket-positive-h-patch-cbd-data\" target=\"_blank\">data</a>.</li><li>MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/news/3498857-mdjm-reports-1h-results\" target=\"_blank\">1H results</a>.</li><li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) <font color=\"green\">+8%</font>.</li><li>VistaGen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a>) <font color=\"green\">+6%</font>.</li><li>Gold Fields (NYSE:<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a>) <font color=\"green\">+6%</font>.</li><li>AngloGold Ashanti (NYSE:<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a>) <font color=\"green\">+6%</font>.</li><li>Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"green\">+5%</font>.</li><li>Harmony Gold Mining (NYSE:<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498871\" data-linked=\"AU, HMY among premarket gainers\" data-tweet=\"$SINT $VLRX $MDJH - AU, HMY among premarket gainers https://seekingalpha.com/news/3498871-au-hmy-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3498871-au-hmy-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498869\" data-ts=\"1568293405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498869-ubs-upgrades-abbvie-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS upgrades AbbVie in premarket analyst action</a></h4><ul><li>AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) upgraded to Buy with a $79 (14% upside) price target at UBS. Shares up <font color=\"green\">2%</font> premarket.</li><li>Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) upgraded to Outperform with an $82 (16% upside) price target at Oppenheimer. Shares up <font color=\"green\">2% </font>premarket.</li><li>Varian Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/VAR' title='Varian Medical Systems, Inc.'>VAR</a>) upgraded to In Line with a $123.50 (7% upside) price target at Evercore ISI.</li><li>Genmab A/S (NASDAQ:<a href='https://seekingalpha.com/symbol/GMAB' title='Genmab A/S'>GMAB</a>) upgraded to Overweight with a $23 (16% upside) price target at JPMorgan.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498869\" data-linked=\"UBS upgrades AbbVie in premarket analyst action\" data-tweet=\"$ABBV $SGEN $VAR - UBS upgrades AbbVie in premarket analyst action https://seekingalpha.com/news/3498869-ubs-upgrades-abbvie-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3498869-ubs-upgrades-abbvie-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498865\" data-ts=\"1568293024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498865-krogerplus-1-after-solid-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kroger +1% after solid quarter</a></h4><ul> <li>Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='The Kroger Co.'>KR</a>) reports identical store sales rose 2.2% in <a href=\"https://seekingalpha.com/pr/17630130-kroger-reports-second-quarter-2019-results\" target=\"_blank\">Q2</a> to top the consensus mark of +1.8%.</li> <li>Gross margin was 21.9% of sales vs. 21.3% consensus and 21.5% a year ago.</li> <li>Operating margin came in at 2.2% of sales vs. 2.0% consensus and 2.0% a year ago.</li> <li>CEO summary: \"Gross margin headwinds in pharmacy were offset by strong fuel performance during the quarter. We continue to reduce costs and are on track to deliver $100 million in incremental operating profit through alternative profit stream growth. We delivered strong free cash flow and are now within our targeted net total debt to adjusted EBITDA range.\"</li> <li>Looking ahead, Kroger backs prior guidance for full-year EPS of $2.15 to $2.25, which has a midpoint above the consensus estimate of $2.17.</li> <li>Shares of Kroger are <font color=\"green\">up 0.82%</font> premarket to $25.75.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498854-kroger-eps-beats-0_03-misses-revenue\" target=\"_blank\">Kroger EPS beats by $0.03, misses on revenue</a> (Sept. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498865\" data-linked=\"Kroger +1% after solid quarter\" data-tweet=\"$KR - Kroger +1% after solid quarter https://seekingalpha.com/news/3498865-krogerplus-1-after-solid-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3498865-krogerplus-1-after-solid-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498864\" data-ts=\"1568292999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXE\" target=\"_blank\">FXE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498864-stocks-move-higher-euro-lower-draghi-speaks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks move higher, euro lower as Draghi speaks</a></h4><ul><li>Speaking at his press conference following the ECB rate cut and restart of QE, Mario Draghi say the economic risks remain titled to the downside.</li><li>The ECB staff also cut its growth and inflation forecasts across the board, with inflation in 2021 now seen at 1.5%.</li><li><a href=\"https://www.ecb.europa.eu/home/html/index.en.html\" target=\"_blank\">Live feed here</a></li><li>The euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='Invesco CurrencyShares Euro Trust ETF'>FXE</a>) is adding to losses against the dollar, now <font color=\"red\">down 0.65%</font> for the session. The Stoxx 50 (NYSEARCA:<a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>) has pushed its gain for the day to<font color=\"green\"> just more than 1%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498823-ecb-trims-rates-restarts-qe\" target=\"_blank\">ECB trims rates, restarts QE</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3498864\" data-linked=\"Stocks move higher, euro lower as Draghi speaks\" data-tweet=\"$FXE $FEZ - Stocks move higher, euro lower as Draghi speaks https://seekingalpha.com/news/3498864-stocks-move-higher-euro-lower-draghi-speaks?source=tweet\" data-url=\"https://seekingalpha.com/news/3498864-stocks-move-higher-euro-lower-draghi-speaks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498858\" data-ts=\"1568292879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIP\" target=\"_blank\">ANIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498858-new-coverage-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New coverage - healthcare</a></h4><ul><li>ANI Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a>) initiated with Buy rating and $76 (9% upside) price target at Guggenheim.</li><li>Agios Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a>) initiated with Outperform rating and $45 (19% upside) price target at BMO.</li><li>Alexion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a>) initiated with Outperform rating and $149 (37% upside) price target at BMO.</li><li>Aptinyx (NASDAQ:<a href='https://seekingalpha.com/symbol/APTX' title='Aptinyx Inc.'>APTX</a>) initiated with Outperform rating and $7 (72% upside) price target at Wedbush.</li><li>Arvinas (NASDAQ:<a href='https://seekingalpha.com/symbol/ARVN' title='Arvinas, Inc.'>ARVN</a>) initiated with Outperform rating and $34 (38% upside) price target at BMO.</li><li>Bausch Health Companies (NYSE:<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a>) initiated with Buy rating and $30 (30% upside) price target at Guggenheim.</li><li>Corvus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals, Inc.'>CRVS</a>) initiated with Buy rating and $7 (69% upside) price target at Mizuho.</li><li>Emergent BioSolutions (NYSE:<a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a>) initiated with Buy rating and $65 (19% upside) price target at Guggenheim.</li><li>EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) initiated with Buy rating and $4 (150% upside) price target at Guggenheim. Shares up <font color=\"green\">6%</font> premarket.</li><li>Forty Seven (NASDAQ:<a href='https://seekingalpha.com/symbol/FTSV' title='Forty Seven, Inc.'>FTSV</a>) initiated with Buy rating and $18 (125% upside) price target at Mizuho.</li><li>HealthEquity (NASDAQ:<a href='https://seekingalpha.com/symbol/HQY' title='HealthEquity, Inc.'>HQY</a>) initiated with Buy rating and $74 (26% upside) price target at Deutsche Bank.</li><li>Healthcare Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/HR' title='Healthcare Realty Trust Incorporated'>HR</a>) initiated with Buy rating and $38 (15% upside) price target at Berenberg.</li><li>Healthcare Trust of America (NYSE:<a href='https://seekingalpha.com/symbol/HTA' title='Healthcare Trust of America, Inc.'>HTA</a>) initiated with Buy rating and $33 (18% upside) price target at Berenberg.</li><li>Horizon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Therapeutics Public Limited Company'>HZNP</a>) initiated with Buy rating and $36 (35% upside) price target at Guggenheim.</li><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) initiated with Market Perform rating and $85 (8% upside) price target at BMO.</li><li>Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) initiated with Buy rating and $5 (355% upside) price target at Ladenburg Thalmann. Shares up <font color=\"green\">5% </font>premarket.</li><li>Medical Properties Trust (NYSE:<a href='https://seekingalpha.com/symbol/MPW' title='Medical Properties Trust, Inc.'>MPW</a>) initiated with Buy rating and $22 (17% upside) price target at Berenberg.</li><li>Omega Healthcare Investors (NYSE:<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc.'>OHI</a>) initiated with Buy rating and $47 (16% upside) price target at Berenberg.</li><li>Physicians Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/DOC' title='Physicians Realty Trust'>DOC</a>) initiated with Hold rating and $18 (4% upside) price target at Berenberg.</li><li>SINTX Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SINT' title='Sintx Technologies, Inc.'>SINT</a>) initiated with Buy rating and $3 (100% upside) price target at Ascendiant. Shares up <font color=\"green\">55% </font>premarket.</li><li>Ventas (NYSE:<a href='https://seekingalpha.com/symbol/VTR' title='Ventas, Inc.'>VTR</a>) initiated with Hold rating and $72 (1% upside) price target at Berenberg.</li><li>UniQure NV (NASDAQ:<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) initiated with Buy rating and $67 (41% upside) price target at Mizuho. Shares up <font color=\"green\">3%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498858\" data-linked=\"New coverage - healthcare\" data-tweet=\"$ANIP $AGIO $ALXN - New coverage - healthcare https://seekingalpha.com/news/3498858-new-coverage-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3498858-new-coverage-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498863\" data-ts=\"1568292864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498863-atvi-gains-bull-on-warcraft-strength\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ATVI gains bull on &#39;Warcraft&#39; strength</a></h4><ul><li>Nomura upgrades Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc.'>ATVI</a>) from Neutral to Buy and raises the target from $49 to $64.</li><li>Analyst Andrew Marok cites the \"strong, above-expectations engagement\" for the recently launched <em>World of Warcraft Classic</em> game.</li><li>The analyst also praises new Overwatch features and expects Diablo 4 or Overwatch 2 announcements at November's BlizzCon event.</li><li>ATVI shares are <font color=\"green\">up 3.1%</font> pre-market to $56.60. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/ATVI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498863\" data-linked=\"ATVI gains bull on &#39;Warcraft&#39; strength\" data-tweet=\"$ATVI - ATVI gains bull on &#39;Warcraft&#39; strength https://seekingalpha.com/news/3498863-atvi-gains-bull-on-warcraft-strength?source=tweet\" data-url=\"https://seekingalpha.com/news/3498863-atvi-gains-bull-on-warcraft-strength\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498862\" data-ts=\"1568292731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APLS\" target=\"_blank\">APLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498862-apellis-pharma-prices-convertible-debt-offering-shares-down-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apellis Pharma prices convertible debt offering; shares down 8% premarket</a></h4><ul><li>Apellis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a>) is down <font color=\"red\">8%</font> premarket on <a href=\"https://seekingalpha.com/pr/17630080-apellis-pharmaceuticals-announces-pricing-offering-convertible-senior-notes\" target=\"_blank\">pricing</a> $220M 3.500% convertible senior notes due 2026. The notes will be sold in a private offering to qualified institutional buyers.</li><li>Initial purchasers are granted option to purchase up to an additional $33M notes.</li><li>The initial conversion rate is 25.3405 common shares per $1,000 principal amount of notes (~$39.46/share).</li><li>Net proceeds of ~$212.9M will be used to pay the cost of the capped call transactions; to fund development and commercialization of APL-2; conduct research activities and for working capital and other general corporate purposes.</li><li>Closing date is September 16.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498719-apellis-pharma-launches-200m-convertible-debt-offering\" target=\"_blank\">Apellis Pharma launches $200M convertible debt offering</a> (Sept. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3498862\" data-linked=\"Apellis Pharma prices convertible debt offering; shares down 8% premarket\" data-tweet=\"$APLS - Apellis Pharma prices convertible debt offering; shares down 8% premarket https://seekingalpha.com/news/3498862-apellis-pharma-prices-convertible-debt-offering-shares-down-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3498862-apellis-pharma-prices-convertible-debt-offering-shares-down-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498861\" data-ts=\"1568292479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYG\" target=\"_blank\">LYG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498861-european-banks-slide-after-ecb-cuts-rates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European banks slide after ECB cuts rates</a></h4><ul><li>European banks slide after <a href=\"https://seekingalpha.com/news/3498823-ecb-trims-rates-restarts-qe\" target=\"_blank\">ECB cuts interest rates</a> by 10 bps and launches a \u20ac20B stimulus package aimed at softening an economic slowdown.</li><li>In U.S. pre-market trade: <a href='https://seekingalpha.com/symbol/LYG' title='Lloyds Banking Group plc'>LYG</a> <font color=\"red\">-3.5%</font>, <a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank Aktiengesellschaft'>DB</a> <font color=\"red\">-3.1%</font>, <a href='https://seekingalpha.com/symbol/RBS' title='The Royal Bank of Scotland Group plc'>RBS</a> <font color=\"red\">-2.2%</font>, <a href='https://seekingalpha.com/symbol/UBS' title='UBS Group AG'>UBS</a> <font color=\"red\">-2.1%</font>, <a href='https://seekingalpha.com/symbol/BCS' title='Barclays PLC'>BCS</a> <font color=\"red\">-2%</font>, <a href='https://seekingalpha.com/symbol/SAN' title='Banco Santander, S.A.'>SAN</a> <font color=\"red\">-1.7%</font>, <a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a> <font color=\"red\">-1.7%</font>.</li><li>European bourses are modestly higher, however, with France's CAC <font color=\"green\">+0.5%</font>, Germany's DAX <font color=\"green\">+0.4%</font> and U.K.'s FTSE <font color=\"green\">+0.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EUFN' title='iShares MSCI Europe Financials Sector Index ETF'>EUFN</a>, <a href='https://seekingalpha.com/symbol/IXG' title='iShares Global Financials ETF'>IXG</a>, <a href='https://seekingalpha.com/symbol/EUFL' title='Direxion Shares ETF Trust - Direxion Daily MSCI European Financials Bull 2X Shares'>EUFL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3498861\" data-linked=\"European banks slide after ECB cuts rates\" data-tweet=\"$LYG $DB $RBS - European banks slide after ECB cuts rates https://seekingalpha.com/news/3498861-european-banks-slide-after-ecb-cuts-rates?source=tweet\" data-url=\"https://seekingalpha.com/news/3498861-european-banks-slide-after-ecb-cuts-rates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498848\" data-ts=\"1568291028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498848-wynn-resorts-warns-on-macau-trends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn Resorts warns on Macau trends</a></h4><ul> <li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) discloses in a filing with the Hong Kong Stock Exchange that it expects Q3 Macau operations' casino revenue and adjusted property EBITDA to be negatively impacted by \"significantly lower VIP gaming turnover.\" The company says the lower action is due in part to the ongoing U.S.-China trade dispute and disruptions in Hong Kong SAR.</li> <li>The casino company sees July-August total operating revenue of $1.01B to $1.12B vs. $1.15B a year ago and adjusted property EBITDA for the July-August of $225M to $248M vs. $339M a year ago.</li> <li>Shares of Wynn are <font color=\"green\">up 1.46%</font> premarket to $115.99.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3498848\" data-linked=\"Wynn Resorts warns on Macau trends\" data-tweet=\"$WYNN - Wynn Resorts warns on Macau trends https://seekingalpha.com/news/3498848-wynn-resorts-warns-on-macau-trends?source=tweet\" data-url=\"https://seekingalpha.com/news/3498848-wynn-resorts-warns-on-macau-trends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498847\" data-ts=\"1568291019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNA\" target=\"_blank\">MRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498847-moderna-up-2-premarket-on-pipeline-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moderna up 2% premarket on pipeline update</a></h4><ul><li>In connection with its R&amp;D Day today, Moderna (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNA' title='Moderna, Inc.'>MRNA</a>) announces <a href=\"https://seekingalpha.com/pr/17629723-moderna-announces-positive-phase-1-results-first-systemic-messenger-rna-therapeutic-encoding\" target=\"_blank\">positive data</a> from a Phase 1 clinical trial evaluating escalating doses of chikungunya vaccine candidate mRNA-1944 administered via intravenous infusion in 16 healthy adult volunteers (six received placebo).</li><li>Antibody levels predicted to protect against chikungunya infection were achieved within hours and were projected to be maintained for at least 16 weeks at the middle and high doses. No significant adverse events were observed with the middle and high doses, although infusion-related reactions were reported with the high dose which resolved spontaneously without treatment.</li><li>MRNA-1944 encodes for an antibody (CHKV-24) isolated from B cells from a patient with potent immunity against chikungunya at Vanderbilt University Medical Center.</li><li>The company is developing mRNA-1944 with financial support from DARPA.</li><li>Based on positive three-month interim data, it is <a href=\"https://seekingalpha.com/pr/17629719-moderna-announces-positive-interim-results-phase-1-cytomegalovirus-cmv-vaccine-mrnaminus-1647\" target=\"_blank\">advancing</a> its CMV vaccine candidate, mRNA-1647, to a dose-confirmation Phase 2 trial. If all goes well, a pivotal Phase 3 study will follow.</li><li>Shares are up <font color=\"green\">2%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498847\" data-linked=\"Moderna up 2% premarket on pipeline update\" data-tweet=\"$MRNA - Moderna up 2% premarket on pipeline update https://seekingalpha.com/news/3498847-moderna-up-2-premarket-on-pipeline-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3498847-moderna-up-2-premarket-on-pipeline-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498842\" data-ts=\"1568290234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498842-avaya-considering-ringcentral-jv-sharesminus-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avaya considering RingCentral JV; shares -9%</a></h4><ul><li>Update: Avaya <a href=\"https://seekingalpha.com/pr/17629982-avaya-provides-update-strategic-alternatives-review-process\" target=\"_blank\">says </a>its strategic review process is still in progress and the company is involved in advanced discussions with no other details added.</li><li>Original: Avaya (NYSE:<a href='https://seekingalpha.com/symbol/AVYA' title='Avaya Holdings Corp.'>AVYA</a>) and RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) are in talks for a joint venture as AVYA moves away from the idea for a full sale of the company, according to Bloomberg sources.</li><li>Financial terms aren't known, and the deal could still change.</li><li>Last month, <a href=\"https://www.reuters.com/article/us-avaya-hldg-m-a-cd-r/avaya-considers-outright-sale-as-alternative-to-mitel-merger-sources-idUSKCN1VA1JH\" target=\"_blank\"><em>Reuters</em> reported</a> that AVYA was considering an outright sale to a PE firm as an alternative to the planned Mitel merger.</li><li>AVYA shares are <font color=\"red\">down 9%</font> pre-market to $11.89. RingCentral is <font color=\"green\">up 2.4%</font> to $127.04.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498842\" data-linked=\"Avaya considering RingCentral JV; shares -9%\" data-tweet=\"$AVYA $RNG - Avaya considering RingCentral JV; shares -9% https://seekingalpha.com/news/3498842-avaya-considering-ringcentral-jv-sharesminus-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3498842-avaya-considering-ringcentral-jv-sharesminus-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498834\" data-ts=\"1568289870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498834-european-bond-yields-plunge-after-new-ecb-stimulus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European bond yields plunge after new ECB stimulus</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3498823-ecb-trims-rates-restarts-qe\" target=\"_blank\">The ECB minutes ago announced</a> a restarted QE program. The monthly amount (\u20ac20B) isn't that exciting, but the fact that the bond-buying is open-ended (i.e. no end date or total amount set) seems very dovish.</li><li>The Italian 10-year government bond yield is down a whopping 16 basis points to a new record low of 0.80%. The German 10-year Bund yield is off seven basis points to -0.63%.</li><li>That reaction is spreading to the U.S., where the 10-year Treasury yield is down five basis points to 1.69%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"green\">+1.1%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a><font color=\"red\"> -2.2%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3498834\" data-linked=\"European bond yields plunge after new ECB stimulus\" data-tweet=\"$TLT $TBT - European bond yields plunge after new ECB stimulus https://seekingalpha.com/news/3498834-european-bond-yields-plunge-after-new-ecb-stimulus?source=tweet\" data-url=\"https://seekingalpha.com/news/3498834-european-bond-yields-plunge-after-new-ecb-stimulus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498824\" data-ts=\"1568289161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTN\" target=\"_blank\">PTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498824-palatin-tech-up-7-premarket-on-fy-2019-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palatin Tech up 7% premarket on FY 2019 results</a></h4><ul><li>Palatin Tech (<a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc.'>PTN</a>) <a href=\"https://seekingalpha.com/pr/17629845-palatin-technologies-inc-reports-fourth-quarter-fiscal-year-2019-results\" target=\"_blank\">FY results</a>: Revenues: $60.3M (-10.1%).</li><li>Net Income: $35.8M (+44.9%); EPS: $0.16 (+33.3%); Quick Assets: $43.5M (+14.5%).</li><li>Shares are up <font color=\"green\">7%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498814-palatin-tech-eps-beats-0_26\" target=\"_blank\">Palatin Tech EPS beats by $0.26</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3498824\" data-linked=\"Palatin Tech up 7% premarket on FY 2019 results\" data-tweet=\"$PTN - Palatin Tech up 7% premarket on FY 2019 results https://seekingalpha.com/news/3498824-palatin-tech-up-7-premarket-on-fy-2019-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3498824-palatin-tech-up-7-premarket-on-fy-2019-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498823\" data-ts=\"1568289052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXE\" target=\"_blank\">FXE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498823-ecb-trims-rates-restarts-qe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ECB trims rates, restarts QE</a></h4><ul><li>Kind of as expected, <a href=\"https://www.ecb.europa.eu/press/pr/date/2019/html/ecb.mp190912~08de50b4d2.en.html\" target=\"_blank\">the ECB cut its deposit rate </a>by 10 basis points to -0.50%.</li><li>Alongside, QE will be restarted on Nov. 1 to the tune of \u20ac20B per month - that amount might be a bit of a disappointment to those looking for something more dovish. On the other hand, the QE program is open-ended, and that's going to excite the dovish fans.</li><li>The euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='Invesco CurrencyShares Euro Trust ETF'>FXE</a>) is volatile, but heading modestly lower in the minutes since the decision was announced. European stocks (NYSEARCA:<a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>) are adding to gains, the Stoxx 50 <font color=\"green\">now ahead 0.7%</font>.</li><li>Mario Draghi's press conference begins at 8:30 ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498823\" data-linked=\"ECB trims rates, restarts QE\" data-tweet=\"$FXE $FXE $FEZ - ECB trims rates, restarts QE https://seekingalpha.com/news/3498823-ecb-trims-rates-restarts-qe?source=tweet\" data-url=\"https://seekingalpha.com/news/3498823-ecb-trims-rates-restarts-qe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498818\" data-ts=\"1568288553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498818-valeritas-holdings-up-41-premarket-on-positive-h-patch-cbd-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas Holdings up 41% premarket on positive h-Patch CBD data</a></h4><ul><li>Nano cap Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) is up <font color=\"green\">41%</font> premarket on average volume in reaction to <a href=\"https://seekingalpha.com/pr/17629806-valeritas-presents-positive-cbd-h-patch-data-2nd-annual-international-cannabinoid-derived\" target=\"_blank\">positive results</a> from a pharmacokinetic study demonstrating \"rapid and robust\" absorption and distribution of 40 mg of cannabidiol &#40;CBD&#41; over 24 hours with its h-Patch technology.</li><li>CBD was detected within one hour of the start of infusion followed by prolonged elimination at almost steady-state levels still detectable 24 hours after the completion of infusion (total of 48 hours). Peak plasma levels were comparable with a single oral dose of 300 mg.</li><li>The company is seeking partners to develop the technology with their respective therapeutics.</li><li><a href=\"https://www.valeritas.com/technologies/h-patch/default.aspx\" target=\"_blank\">H-Patch</a>, used in its <a href=\"https://www.valeritas.com/technologies/default.aspx\" target=\"_blank\">V-Go insulin delivery system</a>, is a disposable device that is placed on the skin for the controlled subcutaneous delivery of drugs. The company says it combines the advantages of transdermal patches with the accuracy and flexibility of ambulatory pumps.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498818\" data-linked=\"Valeritas Holdings up 41% premarket on positive h-Patch CBD data\" data-tweet=\"$VLRX - Valeritas Holdings up 41% premarket on positive h-Patch CBD data https://seekingalpha.com/news/3498818-valeritas-holdings-up-41-premarket-on-positive-h-patch-cbd-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3498818-valeritas-holdings-up-41-premarket-on-positive-h-patch-cbd-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498814\" data-ts=\"1568288012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTN\" target=\"_blank\">PTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498814-palatin-tech-eps-beats-0_26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palatin Tech EPS beats by $0.26</a></h4><ul><li>Palatin Tech (NYSEMKT:<a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc.'>PTN</a>): Q4 GAAP EPS of $0.23 <font color=\"green\">beats by $0.26</font>.</li><li>Revenue of $60.3M (+192.7% Y/Y)</li><li>Shares <font color=\"green\">+4.69%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17629845-palatin-technologies-inc-reports-fourth-quarter-fiscal-year-2019-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3498814\" data-linked=\"Palatin Tech EPS beats by $0.26\" data-tweet=\"$PTN - Palatin Tech EPS beats by $0.26 https://seekingalpha.com/news/3498814-palatin-tech-eps-beats-0_26?source=tweet\" data-url=\"https://seekingalpha.com/news/3498814-palatin-tech-eps-beats-0_26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498811\" data-ts=\"1568287737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498811-de-cat-downgraded-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DE, CAT downgraded at Wells Fargo</a></h4><ul><li>Wells Fargo analyst Andrew Casey has lowered his recommendations on Caterpillar (NYSE:<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a>) and Deere (NYSE:<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a>) to Market Perform from Outperform, citing \"relatively lackluster\" Q3 construction dealer channel check feedback.</li><li>While the price target on Caterpillar remained unchanged at $170, Casey lowered his PT on Deere to $143 (from $150).</li><li><a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color=\"red\">-0.7%</font>; <a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color=\"red\">-0.3%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3498811\" data-linked=\"DE, CAT downgraded at Wells Fargo\" data-tweet=\"$CAT $DE - DE, CAT downgraded at Wells Fargo https://seekingalpha.com/news/3498811-de-cat-downgraded-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3498811-de-cat-downgraded-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3498808\" data-ts=\"1568287316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IQ\" target=\"_blank\">IQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3498808-iqplus-2-bear-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IQ +2% as bear hits the sidelines</a></h4><ul><li>Bernstein upgrades iQIYI (NASDAQ:<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc.'>IQ</a>) from Underperform to Market Perform.</li><li>Analyst David Dai expects the near-term contact restriction headwinds to start gradually falling away after mid-October.</li><li>Dai expects Q3 to be the weakest period in sub net adds since 2017 due to the quality of available content, but sees content improving next month and content-related costs easing next year.</li><li>iQIYI shares are <font color=\"green\">up 2%</font> pre-market to $19.70. The company has a Hold average <a href=\"https://seekingalpha.com/symbol/IQ/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3498808\" data-linked=\"IQ +2% as bear hits the sidelines\" data-tweet=\"$IQ - IQ +2% as bear hits the sidelines https://seekingalpha.com/news/3498808-iqplus-2-bear-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3498808-iqplus-2-bear-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}